Rare to see American cars in Hong Kong, this is for various reasons. 1) Steering wheel on the WRONG side, 2) Most are crap cars and nobody wants one, 3) Even when you do find a nice one, like the above Mustang and even if it does have the steering wheel on the RIGHT side the Hong Kong transport department are complete dicks about everything and getting it licenced is a mind-deal.

This image is excerpted from a U.S. GAO report:

www.gao.gov/products/GAO-17-49

MOTOR CARRIERS: Better Information Needed to Assess Effectiveness and Efficiency of Safety Interventions

"IN QUESTA CASA / VISSE MOLTI ANNI / E IL XIII AGOSTO MCMI MORÍ / DOMENICO MORELLI / COLLO STUDIO DELLA NATURA / EMANCIPÒ LA PITTURA NAPOLETANA / DALLE CONVENZIONI ACCADEMICHE / COLLA FORZA DEL SUO GENIO / LA CONDUSSE VERSO NUOVI IDEALI / UNIVERSALMENTE ACCLAMATO / GRANDE MAESTRO / GLORIA VERA DELL'ARTE ITALIANA / NEL SECOLO XIX"

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

ôä+è¦øVWAÕ]KUM_äµù]:³r2²¡%Eʱ°Ç[ì´g¸Ù}O+OYºó¨Õm®·Û£Ó©»åº[Bjy&¢ÔÓÕÑçZÊZ$b6i8IJÈ~£'å¬ã¨|-é©u·'éÔCRÇfh±ÒSP/$ù³rܪ¿½²ÜéPÂèxßêt4Tr«E:i½ûìÖ]Í;ª~ÛJdCSÐAf¹&e3eõ{¸ó¢Ö

EÖû^Ö7=5==á·¨CÔåùe[Xa²*zªÒ$ª³~K[\r*Ú\S«Ñ

ûÂßW°­oçÔÄRxyç?wâMOáò¾WW䧳iu¥ó

w¢yjiÛJ*;/#ugrl§Qôÿ<lÄå:éÃá~èñ²²

È÷

mÛ­Û(]9¦ÓÙþ

+éîqÌÜw[T(³\¯QäTÔy~]ñxª)©T

"°¸½·v¸í=xgñ

¨üSV몼»FhHò

#¨ê2*lÓø

]!Îø¤,Oµ-´¸òl;cé`Ë?1Ö©*u[{3©èKê=CäÙIizS:ÉK¨Ú¾¬N¬ãÊ%n,Ê;1°jüÎ}¥3¼Ù°cTOWWÛؽ¹#ëTøY_JD#¦ú-ßyH-Ø$ãeÜ𢡦ßÄ@ï),A"¹

ÿ>øÓsϳg¢z¦1£)2æ­|¦®h7#yÝÉæÞ¸n1ÄÆrÙ¤û ºO<Æ3ÚËåÙø{ 'æIç¦û4õ|í.Y¬ji$jdxe?

¶$áG~2=6¥øÞTÂ4,ãìLÎé©

Rk\r){¥¤ä/3ÂÖãoï_;û 5Õ`ÉMiê¸k'taÞTAv-Ï$Q-"[=Ë£©UêÝåoÙËÔ}¥xVêNi%KgÂÔ¡;ùæÛÂOo[cËj¹ó!¹Ý²Öh¯r{ØÑõºWPAmG]Â6Lƪ

^s;+v7ùv

+RÍ"ýöÞäÈèl×çzfÚX±?±Ro³;*|×a½Yä_·á¾+gûÞwCWY~æd¸¿òãW;Éúÿ=7

)?ÚQù'ú½VKììä¯//x\ÈH±¸.O·üÉÁýѦ"§«´h[å­Ü¿È®¥$Ù¨YFÊËFûÝTê¦Ökì§AoªòÆ5 ò`ø¢¡%

ùHd´6¿¶H/a:ü2!ãZ@_

¿¢®dË*JV6ß,;FWs«0¶*[|Æbgó¤H¤PaÑ}X«ÐzS

L

R±§eNÆk(ö±}Æ«W&½EÇêH¦¥Au7

Tñqõ7ýDZÁ,>W¼o¼*ÏJÃùßóçßv-

cy-$®!$Ĺ0PÛæpÂ¥Ñ7oqRL@því áæøY$êWÍòSäîh7þø~mqide±S!*Yä°;U-ô±¶>cDÒHwS«ÄIi)·86Üïù//Ñòd;-¿_'üGNkeîÒ!er(ùÁønOùâ¥FËj÷9§%Ì¡H¿ój½I÷õÿÑÆÚz

z|H©Ó|ë:sI¾Þx³ýéFâÂZU7½Ô\÷ùûâaÒ¨]e+^YL½÷ÄÍ/cŸäßóùcuv¬p¦²¥lZ¾VÇ,᧥r²-]Duòá6þJÀóÛÜéòtß3§#_1Ê9GSQ½­ÞÜóÛ×óÇN¹F_hªVòEÑ9¤ÅS<rT«QXhÿñsÏ×ß÷z¨ÔËDR0©\b(GÀÊT#æÄ={ã£Ê2~ìZ\¦£x"xS|jð3_Æ|É÷îWáú`¦Yü4×i²Ï:ÞÿÛu)pA#Û:BÁMÁíá¿âùaCY% M9ÓpyÑ¢ý9çél2IlgaÍ(Ó$m æ<ç·~B¨6Í) BH¿O"Ùþóy÷ÄD·"ýa$y7?×n§àd¿õ¿¿Ë#ýâ Å;*O]iªÛyN+Ë°¸ùl4@Ü:@ÒÍ®#Ìl0IZçoi]

ºþIÎ5E§I!­E thµT%É¢ñK@¬³åY}PWxQàã3̼ñrÃh¿1ïÞ_â,._.ÐJ´n¬­ky·v'ôÅ2¡

±_Ù²ù2ô¾#tÍH#ïDoÍ BN24=bÓày9Õ2²dÝìßøÔâ§M¨åÊÚk7EPש0f4£cÊ×Poïêqäýdr¨BÛM&ü*vãêqrØn`ûyâÖkð¿¦.hd-fCµð=áý¯µ28op¼ÛÜå¾"QD!XxöäÞßb®gBÇk)'ßðØò$ãóÄб¹

î¯óoØ[Ðß¿ä¿ß]iÁÈm%ÔvåGÀ?%¹Äܪ§È§"¨,<ÆAä(;êq2Fë +*0=¸%Ç?¦,)'¥KOA"ÛBÿWç´nÓ2±(p%¦ØÊQ½X£¼¶Ö¾ØeÄ)(ÜVV+¹|©=J/uQõãõÅm^ÐHQ;*ÆZäèñ»5f<v*lÀjûиÛÉØR¸ÜAw*Ãñéûâ=Éd_q[<ßS'©ãyufßÝPÏ{sºûaÎ.Ä

&!Ø6¡çÑO'óÄ2RĶÜÛá<ü%]L$Z`»g6ò

ïck;aéóZ ó-ÝÐr?3þx}úÙ0ϦÜY¡§+uvÙq`§så2%<«k¤»àéºkÈÕõ

3ØÊÈÓ$76èÿþøf)$lѵò-csÜsí¨à³Ì]¥aµc+ù~Ärë5[FãÃpö+Åû[ç!g# T{+.ÑÀ'ÖýÎ p@tÀOp7üñM"ªÇ{

%­ÚÞ#0¢ÅAf6þ«ö'-%aøËï˹íúb/)ʾÑîã¹8d#4äÙ×pÊòÇÚ»vðp{MÎØ!ÌP cQëña¼°Bwîßâò-ÑÕ;

ãq.Kàco÷pó°Èò+Ä

¶ñ¾Ã±Aøpw{Û°Ò?\ÓºüW?Þ¢ÝÛ±ý*±V%IøGòîGeî{

ô"uùͼ!ÍsÒ#QÕfU³°lK¿WµO6«©þ%KWËÏO,tßʧ§@×}£¬ÀPw]¬;à-Ôje%ÃìñèsÕ¼³±¡äÞ5¡È Í)rrô3ÅñÊõPB%Ýåðî¦ìì/Ûlÿ¦¹î ¶·*¬

ÃÉQ`ð

¡¼­êJ

A°'¾4ÓÖmg7Ëtñ÷¥$³i§s¥JÊê6§ÈÎ

Ë×Øn8ksnøÇ»çðñéé*±©¨¼¢

c¯øWè.Q×zlõsJù©k(Ú²øÑ5\¯ïå)öhIk/ÍÈÇZμi3³W×P«0JÊ9é1*&2e£|("üâü¤Ò ÙGZýùK5.©Ìj(ÊyQ¢ÐG$í>ÒZ7_1ªÝY c#¢|6u'\çyþYõc7MÕÑÐ@õRµË%!d$Á

7K¶Çé|¥Ã¥]iéV3/ýàe4ùLýî|ÊZÆX)40Ìc$í@Pî¶ò5Ψt§«]kÖFoþfYCME)0<tÔÜC1D[±,ín.YA$ßRwÁ§Ux_êLÝ3¼ÇNO_NI[DS@¡Xáåønïu÷÷

W@zoÇL¾É¤Î3=ï.Çilkê7?3+ɤ°jµmõ#æf|a6¬HWlKQ*"ÙCélGÒG_ÁNÕR$ò¬Fz+ ob!Gs`x±d#{­é·Ýh|i²ø3z¼Î㯩ïñåcÊóÊôå]b¬Tf7§Ì*%e

"2¢å[ª¸B#,wÄ°|xS

ÿ³ÆÛ[Rtú¨å¾(3j|¹LÌLíE

LKOT$y¡3ÊYV&E(¡$bIkµZÁ,A6kOª¯H´³UEåþd²")&þ[Ûh;C0rMìÔñ{

hÒ5,¼«\§ÒðpÊ|ã0£|U1-}°½Åì}?\ec몦Ï󶧥KMîl~VǶ©§ÛUjSoèaU¦¶LÀ¥g×òÔqèF>ýÆtк¤Èó×TDÁäbÌê¥Åîy=±V§ó4Ú7¾G½2iñË,ÕQÆ%¤±ö°8Û!Ìj(ã¼Ê]ØFãsè/ýøÆ[áõDßK}<]¥B¶æàÍ­ÛØ£4qïO({?¿ëßIä0=Æqs+aÀØ=¸Åújh ù-ü©nV3Øço·Ó]Þ^@§«*¼§Ei&EànÃ)+$·7"FnI·¿=±(,6ÖOgÔ¿wÌé(«©nòjéR¡w{ÙÁd:_)ÓÔYÐet¹"

*t¦É(õ#UgìAÁg'ÈίæÏÒ´Û<ϵAJ`ºÉ*¥®­G4´þz:Íou ­Å±YtÝ'úÎ]3¥ëµn²Ï<¦c#Ñù.ûOþÆ.Å=6Jkï'ôC¥="Öº]hýd:&Ë)×U×æƲªµØ´²"ìÛå±°]Ö6\Íõf¨Î3¬¦»Rô§8¯È&5ye]kE\ô2´Éò¥X.1çjU©æ.竵²´(ÅÕé|­7P5VÖ:M櫤ýT Ì´¶cüW.©§Ê¤îÚX$;î8*E¶9¿UtIº®ó½CG¯ú½ÓËT =\»*«§3Ú

îLd+m;I·§|h§|éû®;~©8õÑeôÜë]êwEº5ÒJ

¤5¦EAetòCßgxªG´²vv,xÐX¼2è}3Ò¯ON©uîÏ¢¦ÔWRVÂSò»¸UJ7ÇkÞþ U+̧ìÏ=æ÷àÿ_ÐÑ©´LOUh]Ô4µ

eV3I;ju'Ï!X§c{cÐý:éjôÛBåy^)ié2è{b¤hÍîåÉEg$ØÞ×µñmwM¯Ý÷0(N/ßX9'UòÞ)Ô4ºóDSõfª$¬É¡£Ëâz8+É%t<ùá¹üjLãÂîu§zÔ«8Îk!*ϦËÅ{c~ñE£M·ömQî}q_%ø2òHR®Ï('ܱÄt%ûé}^|ÅkÌíòíTóÓeóÔ(A¹AXêo`>xùѵjzþTSåëK:Ò55E-drCÓGcå@;¾ßw>¸ëjR'Åg°ðm

Uí«Ñ©,uaÝQÔjìî>]+¯(«³ÇÙE.mH´rHXîÙ)FxÆãÜ)7GϯuûQåÞtVMÓ|§%ªÌrªú(ó\Ö©jå¦lâvY¢RÒÃðl^ضE:ÏcÕ¨y]=Ûù¯õ5Þë]uÖ>¡d]9ÓBeï÷|¦ÒÃIOµI¦RKÍ.Òù¤ZöÚzéâsGTêì®|î£Môð­&Y§òÈ,5ÿ²ÔÈÍp΢å#,G¯Å|EÉ(õÏðúv-÷ÝÔh[oÛoÖ[gꮫê_^2ªuNmYQQ/úAUR.H!ltþa¹ÛÀÜÌI;\úkXñû«³¨uÎY§«âNj³'ú»Ó©¨Ì¹ijøui[¡T´â[¢xø;°

{¿*O1§¯¿ø#ؽZëOC¼ÕëÙRj-)tñÒÅüÅX8>Ms{ZüÛï

ù¨ðõá˧zF§ÏFÕ²ÒÒÕVâX©f¬:iäN¶Ök(^à_·>§äu}$ýYÝõUòiÏRg±®_AIgT`òLM4U¶ç¾U$97ΦfúÂåfC]n¡ÏG¦ü±RÒUÐ-d读VÆCðDwÚn.{â)îW

îu]mÖ½áÛEå¤U¤¦Oä¹u4¨¬0F

áVåP8¼Iéú.¨ÒhÚõªËóì«hÁy¤ªE6Ó Ø®Û­ÜXàÃ{ê92çWr¬¶ªÄÕÕ^ZxÚ¢yÜû ÿYoÅïÆ1ýfÉë4Õ"´>(Û1j§F@)Ô33Ù#

<%ÈÚ8ç

]e±gzÛRÕÔZÔñgæ{Ë(a3ée

C0ô.pqÚuÔé¦<ÞÜ{FÆÌæG*¤)fc;#íÎ@µïþ÷ùbÔ·Âp$"AÉ7nø)®,|¶îÂÆç°};£ÿ¤ìß°ÿ<ÂwÈï¨%U°%çÉã°Ås*£ue¦Bß±'¹¿¶ìÌ2|Ã2¢¢:zºÊPËòDªFÖØÝ×pàÜbz̾#J$Ú­Ãr-pò¦<¤1VÒ¶H§A #ÓqwTø[é§Pc¶o ´~d^MäÍÁ¸7ø·ÿ;â2ZÝdp£ð¼^cöqtv²)ü ¹GÞ'óXåÙ

U-ßáùì-Î1ÙǤÙj¿j]uXfQÕ*xU6²óÚþæ^èvqé¯Mã®;5¡ûæN"·eþ\{úiÏÁ~®É3Z*VÔZ^uÌ*¼ubí!rea½TYMkØcÆ×ök§y¥âwéxºç§¦qLŧ>¦å®Ì«'ÌXôÙÆ\zÜH ×®ú«¬5,UI¡3AMòÓTÁP^ oÀV¹çûc-§jÛÝ»¨Í>Ø4VñM*|§g>:

§ÔÓGêUÃ;¶Y3¢NUU#ß,kiºÚ¯,­£/N$a-,y1Âl×Üm#üûã©_L¸¤³(ìf¥F§Èkiü¹Ö"(=£|éÇÉMÿLaE$stEk¹12üÿc^x5Fi¢H¢/·uKFï"b.ºCô(ÄFͽ£;M;ùvæé_â8­!¹nGZíåÄ!ó¥;éiÿmQ»ñ|À¸|±.§ oI<ÿí*6·?@J ùãE²Ú_FS]ü?Sôp'óJFÅ+\ïµAü¿ù#%CF²¹Jµ1ÕÜXA#hý?Æö.O £

Ùc5Ñ'ýGÊþ¤[òùâS4ÌÈÎ2PWöü»àIä2xiÙ<ؼµâÃðBn-ÿxþg!çȲK,marò¯è;ü°ÚÉ$Æo,Å¿Ë3½÷Ámsõs¶ÇòÄ ° z¹æ$çÐÏ,vHåu@òL*a°Í½·ÿ3íRÔìì"`ÔC¹a·ËþXYQSÝi\55Çã-øþ߶&FûHѺJ(¦´*G2³[æþ_

Î)Tô¶åþ^aP$ØnA

ó-¦þÃ

Ýxü{ÊkbÝ**¢ReØCãøp{¹±>¸ÇVt§2§RG$Z9½·ÔÜÒÞÊ-ûã¥C\¶Át(¡.Íi¼ÇjzÂ'ÂCëqß.oÿ\SÍ´ýltó»Ô>Æ+DIf±u½íÏéóÇRí¿vEÖø6ÎÃ*g¹´².RÛ-wm'§ôþØÓÒmÜ

ì%ouWþ3Î5&Êe1^óÉ&çZ¢ÂHÞDdêóN-'ÿcý°¨éÞF8aY$¥[ØÄó}X\_¶!ÅP²9£GF³æü.ûοÏÊ4s¼¢[!Q÷×ëɲK4Èu5?úÞmòõcqÿ«áÌF"IâðÒ@hÐ|Û÷¸÷8#%Dz`DÍ­,6Úòþ#nÿ¨Äôò´rÙE+m¡lwüòÀÙ44R]¬³¢íÚíâÇùWü£»~~ø0zxÃ$¸eaðp|í±±¢@¬RT)]§.!oå/üD!ÏjhÃe4!ÌÒ³ñîßÀ Ã+2T=WÔò#.g;tr.ð«µ#æü%®G¡ï^õ2©ZzÄHÃxðDHKrÇôàayç¥Ê2'ÄVdZ¼¦Èrå»!ÜÂð ï͹>þÃi._ü±a[DªÆ¥;²A®ÞÃóÅmWª[Iä3æ)5I[Üvì÷ï

Ó(¬¼fu׬Åd[BV7òvó$au^þ¿OLPn¿æåm-`,Fa5JÀìÿÕñz¡t-ã3oÉÛ(<q¤.Fa¦÷ÁfzJÞªy¢*l×98á

ÕàwãêÚ#1!S?ZaøGÞ)ånH¶¥êe©¦VWÔPB<Ê*oU%ÀÞ×½¾vÇ4Í$ûÎoW6èÊÍ;°=ï¾ä}í±¥9AâH'Sv»¬Ä~Vüð!%(Ü©7õäþYÄ.ܸWø@=öß©À¨.Å[ä[Ã}-¾FCÛ£þ¢{~CKXª³1ü$\×cLËv·óAa}ò[<*!d`Êû

ÔÜ·qùa«s'Xªó0Ü»Ño@óÃn5.!n@^ß®2?Þ

Ëü*$²ö¿m¿çZÅWØ

;.{ÝåËI70U*I>X7þ¡ëWePñÛâÞö¾!*íezÂØêÌA%xØ×þô¶X'o=ÅÂÆ$pyP?Ìâ9"Ý

¥Àu¹ü

?®c`Ú.£j!òõ8 ©añ$n6/ø¯ëôÂl@IJ¢#¸Eb$kßuûò©T#i.EíñOéÇr-K3ò½øc§1~n£xíEýKâ/Dk\Ë/Ì+²=EMWçsgÂzaMY4¾Kv?)x¯ð©6n1c&ñ]VõtU?Æ_?§4©rçå0F/rwÊüpÏ8áOÃ7¤©NIôð÷Ë[óù~uu>¤e×M'¬òíMÇ6¡¡8¦|¢QdÓVD()éLñ;$ìOÔâ¶ëÊtS£3§é즶¦ß1Zg§G`ÔýñéwðÃ4ËòZ=y©£¬«´Ô)j8iƬÌÂUîFQ·m7 ZÝ.¤¹)yÂv´j´§VójªWDÌ&Î

þ6æ±xEÀì¦/ÒtC¯:¥ò,â^åH±yäÜ<±mgqå6æòö°E°bÏuò4ñ±×z_¯ZCæùsémEB3aI£{Â%¢MüJÛpX_/ÆAU×|^çO¢töa]UÒÓVÄùtï-!JN£ðÔ(mÄ©$Ø

¼FX^îDù0:ÏÄQ+²lûHçú7.¥Êèk!¡­ûº:G4¥ZÁJív\ʤnqìg¦£\³ïsù{¨hÜ

;Åã*~`võ°Æ:ëu»ÂgÈüöJjâ²J1:QÛJ¶Ò®j5Ô¸ÜcÕ.©åC¨«ó,¶i%5¿Í2µDÏ24MÉä-»^Øñt5M.æí©SÄÓ{ávÛ±¹S©lö69´OZr($Jz´BE[G4r0Q$¡B³Å¶^ücë>¯6G÷zýW$MJigDháf1¼ÈTØrÅn×=¦4´K¬eÓõ&åY.9U¦sz

êfÊó8)XìY¤¤bcÚÛØÏtNÐê

ÚØö®)T_»CMr<U)»_^{céÇÙazULÍðùÔHoîò;ÛmíM|ÿ¡ºÉüKä{#U6o=ñ©î1/cT·ä)Iâ9·cÊ?hÛ×hý!g9vi[ESféHE<ÒÅ&ÅˬvÜ^ÁnI¹=±:/÷^éÉ5i#S}Þ¾¶¡DKæ·òn@ Ø{cÔ]´n/á^Xñí|Çs]¼²ÊÚvg¯¬iÒZÉ

±mu#óÈúc/YJ'¸1¢ö-Ç8ÁMvfÉ_!ÛYGħb½EsSÆ8F]Ö;õàÚß,KYgNÔË4µbÓ<ÉØn-`

ý¹ídsÓTÔTÖ: {(A%ã@;[Ø_Ãà-ËRíE\C¬ýiÿÜγJ¾«0+¥©)`<Ù]à@H¹7°÷8xY.· êÔT×sõWÁ§M¼rdY.}©è³,õhâê)&ûlJèE22

×rÞÆàØãmé#Ðm,ôW.¨¥?¼ÖÕI÷êåNÁ¤ {aëlmÝO-S3NÑB³ooÙ}eB@BS<±³ÞåÀØ;÷¾2ѧmKÁÆXss"j»Ra±}c6ólò«0bl@v·Ï¿#ÜI¾Äy¦[kK¶Zl¾°wùô©&åöäwúãVÍz óÙ-Y¢4¤Í ÖL¢Üú]TsM&·/§{^ÚûÌ4zm=1Zm'KbTÑTÔÒXßÿ©È1'ÿ:îAÆ,ÎõÎV䩦ªhÁù«¸ùbQ1bÖ+ôôÏêt6ªGZn¦õoÂHôóÆÈ:Vý®N(éV«Ñ­QUÔêªú7$³#µBÊ{ÿ¶"³ÊdíÅ©ÒYõLÆUSëL³o&[e4§&Õ0Jôp¥ÈBÉK¸¾/Ux}éÖéu¤çÑÝ@¢Ésê¨kçêóJªiâ!£)Wxi1ýñª5æ¾#$¬ æ£FyÏÜiC'Ño©^£ÖHê¨NTËWSj¬¾¢,¹Þ-ÄEñµÈ½±Þ4m¨)éÖ-W¥i¦pBC>h¢Co{;g¯V3RÙ"Õ¥ÜA=³ôhÜ4îysü1ÉsjW}Æj:Q1î7)#òïZêÔ:<Ë௯¢§®­¨bfaxÝöááAàÛØçj3

:]SãûRRSéÆæï5$R¤¸"Fæÿðâ¦:È2دE8qi¹7½Ç#pô%2N%7ádMm9ýÑÎÖ-häV<þcÖ²ê'ÝjÎ[&MQÖ­)®¨¥U{ö4äí5ê¨ç³[¶=*][aRQyÁ­Ôi.ëhk$ÌôNCËj$§)UÀ%øOÀÿ¼~aj@7¶µx]é^´VÚb/¢²±^¦Jf$§Â@þdM½}m)<´vhk´Òé¨Þ=w0ßìÈéÎjµb0ÔÔ°ÿ/0 -e³¥ì¶_ÐcHÌþ˲©¥¤ÖµN~êÐ(¯ËÒÖP7î­±¦Iá§ÒØøöêÕb¤30û*u¥ÒÿJfÒÓ¸U2ÏNd½È,d^çßú@ÃWømñ!¦tö]ãùYFç0ÎÄ[áÁÀµÓ×^÷NÌüS¤_¥çÅů_Sènug =CËu0Ñ5FziMfUB©)«¾:üÎhÚ:5ø¢4r9¸ca´Ó`«/õ[åzóÄÏO¨©§Ëëu&¯=l¦j¡NDSÅäE2±7

@'hcÇ­-u[WÑéõOY5Å_Yåå¹m.ï»eTÍ"í

]2K4¥LXE8â)ws5Ò:ÜéZõyCE¨µ2ýã?Íè÷TUnR¸X©â[bØ9ä|FøÝzÓ¨4MâÊò©ä£Ê²¾if¦$Í÷¸i£V\7¸HÄqïPo&åP9+KSW»Í}ÄÌÅÉòq$nO8YÕQdõ+-LBIf~1K{©4ãäú¦¥'ùeÆñywQk[y>ݱË5ucÈ»á§M·q5âuí6³dOæQ÷¶ÍëùóÄßé­<ÒAR»¹ n\Kó¢Ä5VÞgþ&Ýwü¯.øÜûJS yºo@åÚ§X¬ñÓÕKU0J,¡Ý7ñî+Vëðªî±$Üc«¥Ù+ªêx]þjܨG(ó&ñ7ã3¯¹¥Vi¦gÕsÑÑG--¨rúZ

ên@<Å

Ȥðk

N7]+öxð¿eTÝnÐÕÙD ?~Ì+2Å¢¨\Ùa¨ù,OÂ,âÄîäkq¤i5aözÄû}LTî«'Õ(ì{Ãï\´w¾ÃªtVbÕy{YéæQ]¥wySGrQìoìÃmºm4êîÜ~+û|öêÚt*ÊNQÔÔ´ù

ºÄÛðá¿Ñ¶EܶUº÷Æ\nII)rh©X6ÐÍÁçôànûNºQáû«óè|î»7|Ï/

<ΦͤÊæFÜܶÅm£¾:6uK©8Rß$'V1ÞLîÔF:<åuuDÀÜ2A#``¬E§¨&Å­É·½½mÛåu`v1Ù¬Dôòìòl-pã=-e5

W6×´nãiÞ¸´õ1`I

¾XM©peúA-hÝÀ³?¨û`à|òU`VUTfqíës¸!T.Ñøn?\

]ÄS¤Ì¥Ì¤)LøÐÿ5YÍDa=Gi~6òÁÒG«±áiI>CZÜÊçÿ_ÛV>A}°6ÊN-hûÿëÔûarU`Uò÷

µ4lçkÞOÎçõ8h­ü¸ÔÄ¢C Ú"Oþ)>®!ßY"µL°cMó§Ýà[ÚÒ!_·üÇËdUEx·ÕÀ-þÚ¡lýÓßHy

Gû£JY£Sȵ2n73HÀ·õÞÿ&1K´LYiܤ¬

÷HãùkóÚoùßæq¢1++:Iå®Ýܲ

ùô»òö©ó¼ÀÀ#ÍÁ´Íù-çLaTP+¤®¬²¨#³©²/ü1óÝTC"yªÑä·"$m÷ú¹<záÇÉìC ¬³SÆeiCÁE¼kaè£Óß¾!ZbËY¤ùTæÿamïú%GÉW¥ÀzQ~äJÿ.ÇÿC¼Ååµ"ÊL-ºíügúØýù{`OfWMÐÀh3e£SG&e·æñ!ùý­}´ý

5©©ÚTeþPåãø#_ü78Þ®jÓ§c&h¤ç-Òt÷(£

c8ÉL²]Tkø*òäuùL´xJbÈÑÕÎ ÿ¬3

Éÿºôãú2Níæ®PÉðÙRGSÀ=yù6y°|0H@

Ú~l6ü*·ÿß3ýìYcilÄlüÇ×ÿº»êq ¢r#-¹Ä«ù/Æp"¯ú»¢Æftøç!?R&)hn

DÙ¥H­Àvþaè«ðLØÔZ¡?ý

ªV~q$FDOÛªÅÐr,jÜ·ÑSx&iV6

0´²ésÀ÷ÄÊäIK#Æùmøy[-Gÿb%°sÏç/Ç+4

Ëm_Â}øAOç

ÒAp:®øÖI&¨]Çù¡O<×åüþX:lÞ²;­®nÉôøYB'4´zã6¤3ªuÉCo6¹äûÉÇå®wÔúü¾,,ôÕy§åv©`XE«®ÑôÄÕÞ

ò®6ûþ¸héDdx,»Ã?L"]ÌeÿÛ¸ü±¢hÍ^æ0I¸±þ£¶(tÙÂüEl°ÿ\E:vÕQøÛäØh$ÈNôbuFq~ÊÁ-CDMíð¿n

LJHàêÔßa2YÍǦêÀÎ ùcéþDiÔÈwݵáCØ}pâ[È«¸&ãåÙ®<´ô'Ó"Y«mÌa{\úE#<J]¶8îãþ^"0ÊìTðÿî\C+ßäv#°üðÜYh§]§è-.5Ù_Ýa¥Ë4Ó5R©3y¬7A`1«é

¢ÒÔ2fYnÏÕ«AÕEùMU ß-HË#¬(FÑnYÐZÃ-µZÓ·pTºùúgúíØÏ5,®

§2éÎÍók¨2|¦,«.ZÚZZ¸êry*ó!¬usI)þY\åüVmñ¬fÝÒÝ@Í(ëe®×Jú-d¦ ÒJ¼ìÅ5m¶

mÃ⺴ÕoºËK¿c/+ò_AJ8l3ª¶ëÇ÷ÇtðÃáÇ/뾫Ìs)³èih+¤¡ècR4¢ ]¶>ÖgTQÁàqï£YÎ[ÁÓ!û4)æµNK¬³©«QiQ

;Ì)R8ôà_½Æ0ÚÇ §¦]5<È:©©*²º\ÂW¦©¤y«Zf¢VU0

¦9±çb`d%êîUÕQeÔM]¢IQRAUçÉkå«£]~»wbn÷¶7òïpg-¬ÒYüù²,*£o

j7Uccð'ÖÖbÉSKr)1²ík×J§Ðƹä«Z,Âx 2IhÏQå´êƹ?)kpF2IÕ½åekómæ´óAV$Q¢¬òI*dòdþTÄ F.ÕÜàr¼Ú¯#Ì஢ZJºI°K³ÂãÀúå±#Ç'nÑ05.Ê2ÔNª*hÓ*®Z$ÛÔUïñ{ÌEñ6¸ñIu/LÃEiÊÚ)²úºjV¡ª·¤Üßx.79,ÒrÀpñá?´ÕßÚmªîqþþ¬èFç1é74ñ¯¦õô5æôRÅ,òTRÃÑÔS̯PÛ*ü m[(c¼Ü\Ú5Ê$h«å¦©i©ëÚ<Ã*Ö6

ÐÂck!wonµÇ§/©´é¤ñè÷ç9ÜÓö5¹ZzJ£R¸|»1Ë3*èa½%JÌT( þ$cÎ;

Õ¥äaV>ë?=ÕêBtöäçbeHà)8úÑà?NTd8§#:j$x#ʹúzvõ¹~ò~oô´é("XTí¸¦<±#JÌ¥JªÛ¿|aÛ&¦b3´é

¨dÈó=c§2üÍvÈÔuÙ¤0O¸º|.ÀØF®0f°A§ã3ÃyF#:Ï0U²Ù¯hû[z;,ÖùvsAOIKTC#º®6®!÷§!vPyþ¡kâ,˨ҧÑN­5×½õÉÊ£*uWXãq{%¿¹AKSýÞZj9uR Øö¿Ï)#÷)ËîvjxÍ1

v-ØÀâ%Ê2âI¥1>@p

¾#ÚØOm²Y¹K»jÀ[M¾wÅ­i"Q¿cè9¶h¬

Å^$C¼¨¸/{}O®Å¾FCu»Å¨ >u(à¡7õ¾)O[T쫵QÜÞö>§Û¥Ø

k«

-YUWM»î¹}dé&ÀaóÆ)Ìç­éMeªñæ

§TPÒ#¥=Àñ¸¸Põ8×Gu%uÙç~8?ÓÝuh<¿MÓiIüB·6Í`jzÛ0&Ò"Aµw³8Ô°o,ÚÖãªôÛÆeYz»È9RµU9ø),fÏÚʼ®ÈvîbO|n«A-ÑÏL³³eÒË3äs{1&À_°Å3Òæ95yu

B"íu:Hü2úã÷{áZ¤WºÚ'Ëòì»NÃ$9vWepO'ÑÒSGNö¶âZÀsßb&Ön6fQ45+³âI

;]CXÞÆßKã¥Óäáú

IÔËeÉ:פÔmOFÀZÕÐ}ê1³ÓÉt¡ù

çå

áé&ç$ÙéBZ³Á7¿Ï_Ä'Mõ®©ÖÒE¥aGK¨i¨álî?þ6å"i)zLÄD,ê W$sÈ«t<¬§Jyj ZFï2¢¦½ëd6r§â+I4®}½Æ8ÖaÁ¡õ)¬ÖéYgU²fåëVÕ¼tâ]£ÉøÑíhìÀÕ* ø5Êâ©A1uzuëUë-ÕG¦Ó)Ìhòì¿ïÁ_Y:>KOyDÔ°#ÌÈÑ %غÁâS$Î*ÚÚ:ª¸buzV1Ô¶æ¼Å´æ£¨ÚOà>Äâ3RieÜ`ðÌ^¦Ó>Õ9læWEÔG*$t!BØûê9¿7ÆÞúE©s

©i²,¢

*uÃócd|a]VBq}¤vc3¶§?å:5ËÚQéGÕ¢JtYÞp¿cå:ßåðñóÆ>¯=Í÷ì156°Q_o×k¯8ÑÕ,Kvz1ÕU1ÔWÒéɲÇ

µt33l$È·|cµÏK³}¤uf Ȳ\jÚÚmÆ¢¥«¬J¨gRÊQ7¥Ê¨±Ãq¾adÖ:ÛÐÖ×SÓäuù¦§1ËjQ³³Z«xÜt´K@Eþ:î¢é[ªúº7]e¹~µYdy¤©OæGW*"oYpþb

`n/JoÎ̯§irý=EK¹¾¬ÌÖßuþ6Õ­6ÑeÚ¢%R@ì_qqÏôöQ¦êõÞ¥TÏ_6£Ê©hÒ®©V

µTñìÄn»3ýÎÉ=yrÎßÑ*óȳ]UDñÏÐ*ÔÈ<©VOE[ðOøÅ]|£øfì+k|ɵ[%\Ì#p½îáùc1MýÕ@`ç·Ëc¬çvü6äÄbBßë¿éÅô4/Z¡ÝÔzÅüBS.Y¹F¬Pÿt;?%8ð'ÙÝá6/KÍ5Ö³ai½>æÒ sÌıvCÝ_{{îEí|z­&JÞÆ­Êça®ÜêƤm49bÅOCM

Ò$q'¢ª`1v¿%¦Ïr秩§ªk«ÓÍɯMÁüÆ<ß$ú³¹±qÂzÖÓý~-¨³r½Wñ²x£Ôý]ÓÔYy/JóÉòèã«[PDedI0ýg6±%o5l­*ünß°ëWz9>³ôï\ÒuO¦ù>uÔ¢LÛ/²DUaÓ¿£n³I3åòº°¼'ù}|Ï Ç­Tq]¾cIÔÝ'¬u^Gê6Îèâ55ty}RÕ=óJ±Ücr}1ó ÜãÃ

­SiIn4òHÒÜe<`p;·%B(õ?<VÆWyÌHÝb~x·I«<¤{8Q[dm¨)Rs´¸ò7r]vßá7Që|I½ThÞk ôÃk4e÷ùùEl¶x3,#pëßZ9¸þçÐb_1¢ù´ì ÿ½ìO¦J¢%©rÀ÷_Kú`K/,Obô£á{Xðã½¾X\¢±èÐ49*

°u6#h¿ã=MU54_|

RÊb+ÿRØÛ×Ó_§i"«U*ª¨óe,Îào{såN2ÞH\wáÏDê´ÿ^ÑÚZ¨°±ir¨7w¹¹

ƨþÏçÅÙ´Y»RÉQNnâÆÛd·#åÒÓ¨Máľu`¶f¨þÊí9³ü­£©¦Ì|Ò

)Û*06q¢fdU

c"äúò¾ ¿,I

oü@I$zÛêÚ7´

tõy¯dÕ3±ó]ÑÄõ&®HSÆ

fX

÷/*FãsÍýñ§f_f'VrÚ,+­0ÿª¸£ÍéÝâ¤=Ö*nyô÷Ƕ^jT¤·ØØzqötfõZR¨ë]9¨òÜÎY

2ÇC::¥2m+ø=ý1Ⱥïá£7Ðzë1£ ÈõTùDУ

ʲVØA°eM¤[Ï×7

±ªá(ìkÌdö{3f¹D°Í(¢HÅY)AM¸+b?öhÑ'ºîB)aTdI^ûSò÷ØÝË1X)

üêµä?oËçbHÑðm²uýeôbF´#$§d·îUù§óÀå¹$JÓÙ%ÒH~2G]

ÈáPç®Fò£6ɲÖ$cHÏÏú²ºÑÈÈ#TþsOá¦Cy$úÆƲÆÆ(!zfßÄhí"NëxCÂe¼´áÃ0¾ûúÜó÷ÂÛ±IqæEëäÒcó7·ëï¥Os+§i:4øßÒE¼²§f'Ì>ÝÉ¿×V©Å8}ÉðÚTM½ØZ1ÿíëBÄÐ+À$

£A¸¯h£øÁÿ¸ùâ7ù3¬[Ò©ÔÄïÂÆ>J9¶3î\Ç.Ì|ɽ8!·o|FO°ú`aFòEË6ݶ'dêHÂlqúpV=Фx£7/ÿyÇ÷ùǾ¢0îÛ®±ïSS0¾ãókþwùKm

X¥ò¡tDézdÄ![_çǯötü5å(PîðÄÎsoå¥7öµµñ%VQáqL¥Q¤òÜÑÁzZ8ÄÀ»Å½=T-þWÅJÍæ(FÅN弿5~3ÿAô-´µ*ÑÂÉDé¦U¦ÕÊeóÌW¹°ÊO§ô*ßêqBNHò«Ç4/wIo¹·yôügçmñQüQÓjÚPª²RT$i°0}¥Ò'øÛWÿfì+k|ɵ[%\Ì#p½îáùc1MýÕ@`ç·Ëc¬çvü6äÄbBßë¿éÅô4/Z¡ÝÔzÅüBS.Y¹F¬Pÿt;?%8ð'ÙÝá6/KÍ5Ö³ai½>æÒ sÌıvCÝ_{{îEí|z­&JÞÆ­Êça®ÜêƤm49bÅOCM

Ò$q'¢ª`1v¿%¦Ïr秩§ªk«ÓÍɯMÁüÆ<ß$ú³¹±qÂzÖÓý~-¨³r½Wñ²x£Ôý]ÓÔYy/JóÉòèã«[PDedI0ýg6±%o5l­*ünß°ëWz9>³ôï\ÒuO¦ù>uÔ¢LÛ/²DUaÓ¿£n³I3åòº°¼'ù}|Ï Ç­Tq]¾cIÔÝ'¬u^Gê6Îèâ55ty}RÕ=óJ±Ücr}1ó ÜãÃ

­SiIn4òHÒÜe<`p;·%B(õ?<VÆWyÌHÝb~x·I«<¤{8Q[dm¨)Rs´¸ò7r]vßá7Që|I½ThÞk ôÃk4e÷ùùEl¶x3,#pëßZ9¸þçÐb_1¢ù´ì ÿ½ìO¦J¢%©rÀ÷_Kú`K/,Obô£á{Xðã½¾X\¢±èÐ49*

°u6#h¿ã=MU54_|

RÊb+ÿRØÛ×Ó_§i"«U*ª¨óe,Îào{såN2ÞH\wáÏDê´ÿ^ÑÚZ¨°±ir¨7w¹¹

ƨþÏçÅÙ´Y»RÉQNnâÆÛd·#åÒÓ¨Máľu`¶f¨þÊí9³ü­£©¦Ì|Ò

)Û*06q¢fdU

c"äúò¾ ¿,I

oü@I$zÛêÚ7´

tõy¯dÕ3±ó]ÑÄõ&®HSÆ

fX

÷/*FãsÍýñ§f_f'VrÚ,+­0ÿª¸£ÍéÝâ¤=Ö*nyô÷Ƕ^jT¤·ØØzqötfõZR¨ë]9¨òÜÎY

2ÇC::¥2m+ø=ý1Ⱥïá£7Ðzë1£ ÈõTùDУ

ʲVØA°eM¤[Ï×7

±ªá(ìkÌdö{3f¹D°Í(¢HÅY)AM¸+b?öhÑ'ºîB)aTdI^ûSò÷ØÝË1X)

üêµä?oËçbHÑðm²uýeôbF´#$§d·îUù§óÀå¹$JÓÙ%ÒH~2G]

ÈáPç®Fò£6ɲÖ$cHÏÏú²ºÑÈÈ#TþsOá¦Cy$úÆƲÆÆ(!zfßÄhí"NëxCÂe¼´áÃ0¾ûúÜó÷ÂÛ±IqæEëäÒcó7·ëï¥Os+§i:4øßÒE¼²§f'Ì>ÝÉ¿×V©Å8}ÉðÚTM½ØZ1ÿíëBÄÐ+À$

£A¸¯h£øÁÿ¸ùâ7ù3¬[Ò©ÔÄïÂÆ>J9¶3î\Ç.Ì|ɽ8!·o|FO°ú`aFòEË6ݶ'dêHÂlqúpV=Фx£7/ÿyÇ÷ùǾ¢0îÛ®±ïSS0¾ãókþwùKm

X¥ò¡tDézdÄ![_çǯötü5å(PîðÄÎsoå¥7öµµñ%VQáqL¥Q¤òÜÑÁzZ8ÄÀ»Å½=T-þWÅJÍæ(FÅN弿5~3ÿAô-´µ*ÑÂÉDé¦U¦ÕÊeóÌW¹°ÊO§ô*ßêqBNHò«Ç4/wIo¹·yôügçmñQüQÓjÚPª²RT$i°0}¥Ò'øÛWÿ\0Ýcr7

¼YÖý#EýqnH®³ wPì`Ékn?þ Åi¤t¸i7vw³w¯?9KÊø

XóT4$¬S?òÎèË/âÚ×õ»·åuqJcG´4Ávþ2²3D-þöâØJdb67O¼)KE¸IñHÿø¸÷ÄvõyHg@î»{ø?1H&f2,ïéøä{ÿÃÏéy>O6c8§¥hÜ°zPàr±þ#-þ}ïêIEeÁeái¡AH­ËðÈ4;Y{ð[××E¢kÚfV¢dÌþpY@ÛÛd@ý}qßÑKT(O©<Ü=

Ôu¹{;RZp&b9H_ÂÿèboÒî<dùÁfÖÛ

v(§Oú¾Q:¨4ËæòÒÊÂçi°°>øyÆØyÆùùl»#ßðHóÍ5³]@gàúú1Ã;,¡r¤ÜÖÝ\Èv;ÈÀì?î4Q¬mt´w~%?Ð>x2+µÀmÊ@»ûc>:'"®ëvþÉîq$ö%L©n*ÌKTü=v8;H7p½úb§É§±`¹Dü7ÇmøýðJÎÇßøÈoñ>÷á`H6ýÎRà|qIKnõ?\E¢)àc¸6åíf6âÀq·ó痢¬w7­Áì1$vE,+p»X%ݽ0/-

IÿyÇËoÅu³ìøÖÿÔǾ+²¬+ÂïØÆËêäÿ ÀîêÝñùmµXc«OL¶Ì!°PêIòÌåòG$[ò­IdLëCf4!Ï>EL6·;H¿ßLoÁ%EÔû+Tg¹Ì!7íÖʶÞr>/êÀûÜã5ø×Ùà"·WçÕªZ'´õFQº"¦2ãá*¶ú|ÍÅ·frÏJʵMfr¦ªZìÅ£jÆ:Áf8ÖDÚ*!!VÖ¸çãϨs¢«Ud·R÷uÊ¢ÊÂKY#çb<ØLSàÏMããXê­iêòý74ìNú£Hë4«ä<Q¡³m

c8°òH㺴C?Òð²Qi];M

k½EzG$öÌ*$FÎ÷cbÌU¬¶

P[¹8­/F]×êAÑ.·åºï?ÒÚnl1¦Ìj*rjyëbÌv¢c(¥Ö?-Û¸üñî¤ëx´?Nõpí2%+Õ5°-·/kÛêìÖMTºðyXxÔÒãCVAQYYaUE^*^l±ªYå,&)èÃn¸.ÂáKr/"åRR&aæ0ÕOGcæÇM*Å+¦ÁYrAã¾¹Eú=¤üâ´¿º# !TôAkN0=[ÊtîµËtÝe~̲Ú<îéâ(VÃ¥%Rò¸<Üãä¶vº

­ï\ã%Þÿ§]9GnMã.й~±ÌVM¦´RýååZ¹) ËX»cÝo.cO1¾#Ö}éÚe©YO¤òhf­$òÖªeZTCa-¬ï

G¥íUmcQ¡ut§.ë·êhTi¸æHÕõ'©uªd¹NÍ)ÒY"¨þ!EW7ÝÜ<¡RHÝK|GuÚÖzëVË´¾* 3¤PCºLáäGe%#òǹðÖµqq[ȯ.¯w?è`¸£®¨ÞW@3CIHí©8l;üN£üñöoÂ~Tyb.Ä«òÔ@«a·½Í/£þ

ÖK÷sC¬ÈSØcë

*¢¸ Ý(Kbãç'.iïlM6Ô4õRå54ðÖýÞo&VÑ6«XÛs'Ò5G¡zûi

Éò|V8̺íh(Ó5<Ê©

|²ÍJ7Ê÷ß½¬95á9¥Ç^QäÕè<xtÛGT.]QS[C,ÉøVÛÁ½À#Ôãg¡ñiÓ²ºMYCSQ¦eMOU#C-M1RË(Þ

Ê\ÀÆiZUô,Wõ)uÆv鿼ã©fM«r̺Xá*LÁQk$iAÈ;d`°¾7õ>¯ÓÅè,Lê

+Å3T,¿tÝ{+=$}|d[ú5£)áÏá±ÈÂz}·+pAº¸ù[Ó¹Û òF\¨b8©l°[í.tWäz0ºAä]K§ª¤Í²|º²iAd§Pò2CÞÿµýÎ6'N¬¡.¨2*Né̾®JÅÊéi'§;uº¸åçjpH\Y¢éåSEK-^RBC´®%]çsoyC¹ø¯Í»X`ê\!ºó{ÉäÅKÓ¼Ç5ÏZêê¯äSM]qìZÕÏê1Ìü=årT±¢Ë²fâ5yµ¹i?#,Û¿¯?LN2];£DozvKåþ¦f$Ï4}u>UU}ªëYe9Û°Ø"Ú·ø®9·Úòhª(aÕͲ?øT¿ÅkßÉ¿¦+MldWqSTEv4çuÕ$`6\ûâ.^ÐjªÊ`¦Ð9xÜ ûÛÊà¥sçÌ!dI;)Þɼ­»ü<òÿ<MOTÔÓKù(¢Ò_ù{ûúbR|!¤,æI¡ Ñ¡3JUTÿJÇòÁæQÇeSÏ'É

¿

µIä}pEzò¦IâUkÞêª7?3/Ùi¹%CCYë;ê¤z'£R×JÔbC5*·-<[ªd@9ßåße=ñÔ¡MF+Ì6xOÃßPëé,±EYåÈà|ñ¤ëd½^Öysxjj©ò̺²»ÈJ©!s.a`³#̯åµÔÛq(¼=56§MLÓy¯[;ÒÂK±#º»^Á¢\÷²Ût¦Ì-Z¬$r£]D0)*ÜÍKIçJ\®ÆKPô×O뺺ÚF5uð54ò$Ì

ÑT

Ç¥ýñ¬å²ý#C©" ¯Îöê?9BËP²®Vo%)¨»ÝßâÜI"æÀ'Qôìéf·Ê)(jóxtþj½¿~§û^ð¹idÀ̲|S9LJ¶?#¾ÑÓº!Seº1ÔîQfU%muM Y³¸o¿8Ût÷Qµé֩Ϋs<9®0¡:&J´)¤åbgBÌHfÞ×zlßs\μUj¨?ÑÚèòLÛ2Ëóé³*ºº´AUT-¾8MãÍ{Yv¯¾2ñõRd´Zg/«ÉâÏs ËÓ<©Jÿ$RIVþZ:+)i~0ÅÂB¨·|^vB]6ë'O5EmF]fkIX£î«¦[LiÚì)eà]¿WuõÐdUùu}Lÿuj½Òùi6*wqùbÖU©¯~-(ßÛÖþÓûÏ/}®KSá%²È7$Ù¦{G6ß.Ë,ü¾~XØ~Ì®Á 2ª²B·9¥ÏÎÈç³mi

?ó5Óùή6Ãk=ñb¥ö|7.ß?áÇ|Ï_jõDøÃÌe¨¡(Z.¬R{ÓyB1ñÿ3òǽã«eÊRP[Gý

ɳ}WK!I¬LòzbcÔò¤þ'bÅÙm¾ô=DÕUt­÷n?1}õG:¯/ý¢ÚrEY+sHu{ññF

§k`¡ÏsG!Z*gÜ,ܶ·®1cÔЫ<eM½?Å%ØIøOrOÄO»`¤½D.ImÄú}0±E½ÔD¬/g?íé7Éf&üþØàXÙ&p!xÚ}Çõ~øÔîÜOÅßèpáó2D l>x¥aå-¢Ë*ÂXìÕ¸ï\^¡@R½Ðmr,=ûâºôªm$IT^Æ72éQÈïUAGY,ÐA©§IÁU$öpGs|i§ÁgMµë´V¨i£ò÷×Ôn@¦Üsç¢Qù4Âúq[&¬û+z?y­þ=H7Ðfä(à72Ècj±ã§+SÅçz¿(ªy§´ñT*2@- úNØç×Ð\^c¹®§>ìÕ3o±B*sð]cTJ¼¦9lmÊ.`Üöç~{ö1ëj(ø~«Óu&Ð&§¨¦gC à]ÍÏËÚMx½Ñª:¤_(Ô3ÿ²s«ÙpEÍÈE>fg7ûE^Y¸ùjìñë&S»hZÚ8ºÕSÌþ++ÞȸË+«a¨QÙÜçºÃ7P4ü².a¡õ^Z&P#yrÉ ¼HR.Ö6÷¾5 ßñ6 &¡ÈâqPÀTòíþ°¦ÊsQ¯N\2¾àcY­±­@|×ýxÆ{A70k²-à*Wm¬mð/Õ2ß¿ÜH¾}HÙó'TE

ÕNÉ·ñ°ýû`)égXÂeÓ­q,ÝÁúy9?têÓäô®Ëd4ìGÌî~7òÆÊ:ÑUCªµûÄãã7µ¿{'ó=õâÉ4ñìpz°MûÖQÏæ++3Ñ¥ÈoÅÈüûãU¦»uAþî£_y]KxÉå£KÖ>tÛäõE÷'X¤4r2JZö7yHnQȧRÞ\êòýqõ¿jõïéÔuÞ\ZüÏ'¯Ò%FM

ïU@±åÈ.±¾ÓØÿSõ¶2PëL÷)o.Ï0G@ÈY|Ä;¬nUãÚQOÌN

\J~³g´\Õïû­%26ØȺNXâí7|ÞÉ¥È˱´Ûoö£ÁS¡)ÈâóùXD˷ɨæR{vÉA×¼I¦±Âÿ³y¤KÃÊÝö!+oFdiº³§¥ó7f1©§`²»Ëvg2}AGU[I[M+#

dÊÌü_½íòÄ$¹E¢÷3K:UÌ/*3¸þ`VªW¶

ä®àJ³0rx?¶(osBã É2óñü·n

»~øI]¿©·õ'¸ý0È¡ Ü_jñý>øÛÒÌÈ·[#ü=o\h?Ì$Ûóöý0!7ÈEãàí½ûÛôÀ%8ü.¦äÇpªÝñ\`'âO~8'DÆeÊYIU)Ïôç.ʪn¤ùi~áÅ°"6ª°!>DV*I?¶U7qº÷Ø~#ýðȾÞ.]xuãý¡âÿXÄlw$µÜpª}15À&F»Zà÷àHýp,̧{8Þð{Ý<[^áMgrI6Y,2Ò8Ä$­Æ­¯wP¥v môÆ¡§< Óê}?_"glsjjºÚhâ1±ûÇQ+.ФlÜ·Å{yº+¯

nu©oeýyü

«Z&×L¹,ó

çæ¢

|×*«ÍÖ±a|ÄÉÚìewe°;WvÑ}ª

ù°Æ

£Á¹¡YâÉb2ܲæh-¿â¸âæ깿c£k㾦ãlJʤVN_ZË$F«Q´n¸¤?PqEª¾ñ!¸µý½1ì¡$Òìt7ÐôÔz¼g4PÖÍþ±Sñ#RS5ÄE~-îËÛÙèü2æUtÓ_M#ØT§ï*Y×ykYr0çcn1çªëÞ\¥Aìð].Ia©$UÜIFøVçØÂÇÒ

QêrÑ=-]=2Ô´U2¬-±"w?±/{ûb¸k¶Ï*O

vîMÛÍ$ͫ¦¯¥ñ-¥ij饧x³8Ã[VäÝô8ö÷ÿüíÚ×ÈI¥²ÖEH×sHK(°nHÍFq{Ñ[3æé

ÜööÄ *²yÛ»Óô1L`pv|,ÇØâh";B´`·oÃÒ|"2íí·bŬÍ2ÅîÙ¦kMç.ÇÕÈÖÿ

¬ÜúbÚÑÒq>¹%³-¯Tu4h¢]A

E¢Vû{nëµoïaÖDκYKQææ2ÒD)áyQC*muÿSs©éÔæªÓMQ:²k

ôî­ êC#Âò¤YQ?H

ÌÛb|ç¿éM¿­<ôY[1ËÃYl¾Þ¦øãjÐnîù3¥fÿu/©Ö¤¨,GyâçeÌRJvwR7(Ïý*P.êGú.ºûn5Nd0å+]vµöi#ßØO8á¾ë[ø¡dY?jÊ­÷:ïÁúz㶢ð¾ç7}籺¶d§ðé¯|=+ËC2(B¸$æÄóéïKƲôÅlùôå ©ÌzQ]

X©Jyþ®Ü|ñ\W|Îv<å©t­Nè~_ÒxÛvsõ

°Û!IrøO#Ø4߶;§YzAuKíA]ÅY6Ê4ÜtòRÃ1i2âÈ¡m&Ýíl\åþ¬¡Ç;%Ò)Cöski3d¼ÒZ7·Z«Qø¿ÍßÄv,«ÃçH2¬ë1GêZ´®­³Bsj§Låme@¥¶!ݶä÷çÖRaÒØØ|0ÔçÚMxÑù6gÔd:C/«9b½cyÔo®$n(̨o¶Ü­í?Rx®Öº[ÂN©ÉµfpÎgW_]W\+^ie»ÉrV6{Æ*yÇ%¤ÍË|JëZïo-ÌâM!¤´Ê×f=<mçMì\Ãt² <ú=qÅ[í9ë¦é\:ò5Fiæµ¹M}:SÁO5$íÄ^¡ee ÿ#u¥]Gæk©&é¶y#AõÓ­3îç9×P«5vIÔÈ"©l¦¹f¦

§H1q»u0d#nqîâsBRuS7ÑÒg±E¨ò

y*ëé$Uû¤¡ÚFnͪ¤oë

í²½M­ªÉí#x±ñ¹ôÃd]DÐÚ{VÓÔf±åñ°i&¦èîê6!Qô¾]ø̯Ñ×¥y$¹U¯Ô*ZgèRÌÈj¢ä¨Ä?ÓÉÆxY®åó¬ß©3(+ë$¦Öyîeî·6æØç}KñtÏ®WFW岿R'MSGIæRÓÝÊZV$å¿o

OµýOö\C®3/»h,éÙ¿

äÅ¿Þ¸ã#Îèñ'JS.®põyFKpÁÛßÎ1¾$²*ýI§4U_Ä#É3ÍB2Æ%%`&XÅEg"Äh®Ìæ

{4Ù˧¼ð[ªêºÉ¬õ¨I)SCäD¯05­TÔñEðÓSEgmÆîÎn#Ñt]\ÑZ5¦X'ÉòÙò0Σ}­¼VMVàk*¿ºå}VhI?þqqÌ¡²©É

Ï#|6ñ¦U}ü¥YèåŶàCTím£ñ^Øôßö1ú¯_eZ#6Íê/¥+æÌêÄ.æ

8r@íë7Nz­çZ²ÃX»dÉà£A$nIMD®É®¹Á:yqÉÓd¤2*öö8Áæz~j66

n÷ôÃ_2·ÉI3¨ø¹{sld©5³D¡d7÷6ÁØu5­«üË

»bUÔ¹{úF¹Á¸ÆWeñ á[aàzU¨qDçɧݸÁ³bÉF ÌõxÔ-t.¡ã½dïå~#oôõÄ£Â{æ´9D* ¦¨A{#)=íÇ9ΤѶÌrgQ5dô«"w%T;BªÄ¤ú³b{5>È"÷:Ì5*éø-Ë}1

ÕW®ËÖû¯U \ÿ ¶y!£gbÍ3

ºÏÝ^¢I%d4ÈY¯{çÁ´ ¹ME¿Üõü}ñï(øÅÁ(¸pÜû9Jjã-¿ÄlÃÁÞgµyAS"Zh+~`¶5Iú¯4mlÒÓÑÔ¼qüܾ§yú6ü±Ö²ñ5¥Ëq¯©çoü©X¯2ÎnX9WóTëfYFkæ2ª3!

eÃF$onü}{_ß³ÓÅðÑ}§Óe0MdõÓ¤+ì(ds"1î

Ã|±¢óH¡wGÊ¢ð¹ÛÔìi^"»²±uï"å(¾CÔ¹¨Y+jrùw\¥T-ý~%¸¶6ÌSPç-¯¢¯÷&uso 7ý±à¯´KfÜ£ê{m+ÄÖ7ÉySĽ'$ñàW!ñWÖ×fÙ%^YüÖSÝå°kX«\«smÇ|ufÏrô¼=dÃ4ÖËÕ²6ãOK

?ÔÖVbï*]Ô­F«ìÿSµF-Ԣ̵{"¾øÐ=8z

wý/¬È3jÄÌ¢£\Af~å¾Õ`®zî?;x·s¹Æ¼Êólÿ!²°UgBTzyÓlY|ÃvëÚÛ¤µýøïß6É·4U¡+]§|Ø}ÿ<a5$Qft¤I]à`dlßâçó÷ùbQ}JªO¢.^Ë|dfoTí&Mȼ¨LÊåoÚæãöÆnÆ-¡Z¬71å ©Kü¾$úø. :»(£í1)8×¢Ñ˼\é:isê0ßÍ¡ÿ]­þXØh÷Ðô^>ÒëµK¥¿S1Y[¦ú§êòÙs=Ñ×DñIFÅéVàµù>µÕðâ'3ɵ.[®ÆQSBóÁ-,´uª¤Ðme7<÷4ZwôjÎXxÊÉÒ¾AÃ)Æ^£´ç@ò­éxóýª)³Ü¬¡dAÇá%Nå#± Þüc[áÇXdeÕÏ)6uîóîã¹õW= Ló'­¦ Jè%§cèÔ©ý/] ¦­ê¼Ò="/x¨r­W5EL¬ì\KARì-Å£

ÏÈÊ-hÒýÝYK¶ä«>=ïâ÷ª§£^5NwDÌ^è²èË[uDÊR ?îÌ~HqÃþȺ(iºUgÿô¦eEIÅL ³rdÐzbpéÓêTõio÷¾Ðl

zýãG£Ý9I,Ì"Y

ªÓÏ#ùì-êÑ@w 6õÆÑöõK è÷}IM4½/¤¤§

ey|L­,ÁG

«µcQêÌ}6[Âsû-ý2{ì¹Ó?è

<¯2ÓIY5z­¬Z5o"+üÈBI÷cMÕ<2ûK"üCå>:=jÜáAOjjvýn¥Øaõfî?¬xµñF¡AÜW¥$·¨IÓP#Ïf=iâg7êz³03/¯/HÒ/!$iøA²Ú×õÆçÑÿ9WYüMfZ)Ëâ%¤mp&bk&ÜÂÛ-`c7½\+Ý%ªÕcOeuÓK«z²`T¹ÜüýñÕË%^S§#±¨Õ«#öX©¤aûMqhÚ¨²ñLkP¿©8³,ßwPT´nÜà~F¶¸ÖË´n°ç·s4ÁclE»­½~xH\n£é: sÜ¡wÃeõ,?ÅæÄËýÈǧFNé­zõB[ÕâjWk'ðü°Âp¤k~$")Zÿ0}1ßÒjÓjw3ÕËØïØéðjúúÚIGRÅ:ôþ¨Y>ðÛOjJ½]Ñh3Æf ËþîD(×󬒩 üqk^ôÓª³ëü¿?ÌzuÃåõ«TfóL°H V{±¿7<_nméÖÅý2BÄÜÞ:yâë7¡§Í[æ:³,(lþj­7[÷ÚhÛ%¬Å¼ÔNb²±

ÌÌ #ZÍ´n¸<cl´×Ôú^ݲjûJ|Z6Öh¯Ðùvg;g´5GXÿÔ¦©[î§s`ò@ââÀ¾³ëÖéÖuCAê»(¯ÌØ

Zj©BÉ5ûp/`O«Xa­§Vºq¾2]´6Ö4´P4³ÔE

<`VØ~×cÀ1ú_­Ô«ö .EÑ×ÓP¥*ArÝ'-r

øÆhQMúãên©ÓÍ:nÌH±Ú?,W©ÌÙá¨þLVóIäÂÕêÓPÓe/UYdTÁLÇùÅÝG²POÌbÀFE¼kz[

r<YÃzp=þõÛâîG6ôÄÖ9 Ù]¦!&×kÂ=±Z|®;©Y¤¥«iSÊVK²£V>À?Ìî©iãÐiú|èƸ§ÌißvÐ{]ÔÄÜð-´cê?]NÑèç0éÞ©Sgt¢iA±æ=ܽïôR[Bâ-îÎè¼Ó$îõ´Y|ì^5M;ÂÉñÂÆ3u/¿vnqo³º:¦ð¬ôÇO¿ÒJò³EÞV¼4®Ò廤2ñLré`Svy¼õðÊâ[V

Uv!'êR¦­T ÞIã?ËèÿÌĪ®$tc;bWHó[òB~Þ¸ÜÅmå= ¹*xãÐÿXÇþQ­$fÞ²r-n6î·nÿø±l

$nYìÍîAOW6ü­Ô·SV5ËÎ×#±Y9ý¶,2VÞ

RndÚÉüÁÕÇçßDÎ$

/{pq9¿ÈqCÉ$£a

+¡y!yâź%¼Á ¾àÅ;»Já÷Æj¯²"Ìh¼èãeSd"|@ý[°õÆk@äÿ}Î)KF¯,s:ÞÛQ1ùòqͽ«ÓBOätíaÕ4z+¢Zj(ãrxOÌ@¸ä1¹;ã&ßãâ%d÷1Ù jÝZ@9*OøÁ}ÄÂä|_+v¯"l×:»:ÁÓíÆU¢p"÷_÷í#×hü¹éX=-15kíøI

Doùíý±õV©JÞ¤ ñDyaÕ~>«§Tl^97:îI/µ¤'þàb­oMa2!¥Fºükxò7?<}"«Q|hóR è«þ÷ýÎ6CT¦þ-Ýv)O§kb¹¥c_åHÁAÓz7~ÿúõÅI)æEþrÏ

ÈDÿ*

~¿úïÔî)Ëx²¹A­[TâaTEä9)aNÿ¼õß|É3)\ª¢8îlaÚ 'Üþ§m)LñÊ!jXw ûºßlÛõý½°4ÓAh¤¿®#oö%?õÿ^$4d-ÚËÌ_ù)ÍßvimüûcúâHк,eØ

®æãWûaª*^Z v2«òöÐ`

vE@Æ%kZÑ·,ÿ®mR

+¡µ­å¢r§êØ®6Ö0YV¡[l

måþx³EUen¦hÄnÄS2nÙãqMnY2ô=KÏèG¹

T¦;Áµ?7uÀÅên»gpÄ7µ5AReÁ]¼JÜQ¯Óíc>_K(|Êe-kÚ÷àbÔfÊÐÚzj¡å0Ù1nGéÝ»ìBTÌ7TrI×ùµScÉã#K¬òÌÆDXs*$Ñ S

½ïnmÝ9"=/ê\Â:½¯F©]s

$£yÜYPñr;)î\V,Kf47

OSÛrZHÁÿËöcÙo=8 K űc§ÕØħ^¡ên£¦M6£Ìϸ¿þlgò®¼ëúiSêlÙÕö¼Qaî7Ås·Xh®ÓÊfLø¯ê;(þ-¥x&Z[ÿÅúºÞvÈ$×ÿ^ß÷HÆiô[Î<ùàËPøäÔqú|£(_¼fHÏé¸ã5ý uPótÄFÃâòsRßøPôªmå<}°ÌÅÚENDùsîâ9ã~Wâi<cèú?õ¯8~&£È÷ü.1Z]X¼ÂD¼ôÖ,Põߧ5ñ[ï5´Á¹a&_-ÿ8²º¥ùÒ&imnLSÿNqLèÝSyY$¥°É´Q¡W¬ºR]56C5mêÞv¡Ø]PS5mì.}q¾uk¦oQt¬Vq­eß:_ïþ*jèXíÃm¹g>YL¬êÄÃUxSëI9¶Ö

XßwvpO©;a5WH:æ4δ޵t¶ÁWEQ B{p{Û¾4S¹±ºàÖQBªXyÁÑ|xsÌ57Sr*ú¹'Ëꩳxà-T©Õéß!£RáX·-õÇ×nå+ÓÛS©adÓ³ÒGy¤O6@E_¬´¦MÓf0WKüNfEU»þز±S¯©Ç4пg÷S5]ô~§ê©Ès,F-2PA¸/*SÐÄcE7YIÜjzãÂwX©úë×j¼§OÍ?ÔJJjÄhä®%G?Åq!"ÌáAùc­ÊnXá`ÆèIGæYÕ5|~:+¢gÒÙ¼y[VUæÈhÞa¬®@ynà'Þc×jµ'(l¦¬eÙNI£­ziDTþ]+UÁrÒXMý±N/?xKî8Æ«Òók´¦»E½

×eÙ¶¯îÄ+¤a}¦Èv)3ãl$*EOeB¢JuU=loþ!Ì[¶')czôå·ó9?H*eʼøÔèÅ3ÌÑh¤`ÿ¦$ñèÊE¾xÅõó@ÃÁïL)Ú<â®®c.ýÌËv)oÌ,ûÉÿ¾9Êú¿ÁH:e <Yë<£Lgß;Ïò)©j&Í$¦¨¢#$JdIPïgÝe±ïíñâ^ý覤ÉÙ=|jrä®õ¿È[À¾0]·)§#U²Â<ÙÓ½7A¬ºWåù¼¢I×MöÜô}®òNøl5Ï3z\)*Øõî+p@UTøݧÄIã*&úpg¯ºÁç¿ýÏ5

°eZéÌåòÓVO[ëu 2LìiɺÚ@ñØñIuûGSgV]©Ñà7ÒòAQ.ï-éfUM<~"¸{:)ø+TÌְδéíºj

êHÜSE½¤Bû$A÷ä兩øåXô¦ÿ,mðäw©RÐûÆ£do*Su±·çý°uÙén¬Ë/÷ùsùèi?J©×ÿǪ¤½ìÜV#¨Ñ^$¦éäùY>Î ¦D¶Å¢j2Ãåv§có¹Çlñ3ÕZ®tk1Ì¡MXѽ`,Ö©H|Å'¹]÷ü±:)dÓiIÔ}äâ'ÄU/MS§ôFȪ²

ÓJPè*cç¬Ö*i¥&ÂÛÖ;ZÝØÜãÐfuM>r«©¥«§KätZ*3ʱ¨,ÕUjÄÛÙÃRÌ2

{mäO¡<-á»NøÏê÷^õ£I¯ý&¤È²|ÎW«Êa HÙÌ®RH<_GÚ¯:Q£ºóRät¡ë&w¨r*ÜÎR$K¤D¾\oa¶IS`dØÚì?mµf/æúlä~!<_u

s:¦Ñ4ùSÓ ¦ªY^à­KsÛGn¨éïús\jwÏ©ó.Çæyû£¢Ïù@-ì#Î

^ÖM,¬êß&{Âi

/Õ¬£.Ö'RäC§º0¥,»6dI2v°Ü£¾ã`O8.×uÃ(èf]§rüÇ2^£unXÞ¦³2v|%¢¢[͸òäþ}ØÏdÖC­Ýqã?©ywA¦ê3\çYæÙ}VyÍ_x訦6ßÇv#ðlM÷ÌÅ=OoÎá¡ «]m´ùËT)f4Í$ÔºHK­ÞÖÄ\6Øp~¦ñ}¦ÚÁÆÖNeÚ\ëmG[dùt4²´2%<²'Ìfò8»Ø[ã÷ØüDø~ÓúÜSÅÚ¤«¦g%(¥&Kv«#wæØ¡±dqÂ8ïN~Ó}#ÕM+Ô¼ú,·4¦ÊzrRX:<¹31DÎ8FnqÒ¼8øÒ¾&¥ÔJËWPº^¹2ú¦D<aÃGbw-÷-ýJqlESkvBKsõÛÆL³î¤gÝ3Íõ$qIëi#ósØÐÈ"tøUc`¥Ô0i$²eké

çéÞ]ãÍAäo`oo«[ÒÙ3ÚEÿÄÚÀ1­ê]µ£.~éNf<ö¹M£ûá|/(ÎQ,'Íâ£*Êå

,wR¡¿ÓP­è¬R$Èrû·?ÿäHÇJ©uKhÍ[¶]JILÏÂΩvaÍ<Þ*¹ùaóW0RðÕgT¤ûT,üã³mâ»ê\´Ï7{ìÿJ¯ºùJT"]ÔÚ²"Ã-"H?fÔú©ös§ä-Væ9^aL¤´-$rA5;n±ý®;4¬Àû`Ô4ï=FVé<ÔüUINT¯)IGÕ£øðók­miÓÉ4moßátJÜÞ|²wP{

1J¥BÜÜ6÷<Zûìӡ˺MK§2û*ÎLU¸VCEæIRÀV#ôK³\û>3Læõ,JJöª¦I3J¥ÞÃÌÊ1@¶Òlxô¶1ÏMú|jñ¹Ñ©CêìÇ¢}eѽdÖ/3¾xZzdÔM,0Ýc¦'y.ásÍÆ0ýs£¥ñgÑÝS×MKS«´ÎI6cGP,Tõ1Ê¡ØiWz

qg½ÙØv-¶¶©G¢´^ê#*Ôê§õ;G:­ÔάøxÊ©úMKé7¼f9ÖAP

RÇY.\«8äÞ5 1îN5_½pÐ>:K¬êÓ

3ê,Û0JªNÚ5-@C×Ó¥´¥§âØ{[Ôx¸Ñn^N-#©¼VåTäs6g ´¥Mø^ýÿLPãÜQÁÞ ?ëõÅ­ª¨`ø¥3ºÀUPÅJÃl¢]ÃmÔZÖÅ*ªx*6d

Þób,L·-ÿäy8qrÎÂX5Ñô5Ù_YSMKU[¹V@ÏHλú·ûRÒZ(Ðõ¹µFWC,ùÖbÙ¥|XÊUS#\éU-ó$½ÜìEyàïIEÓ

½8#­-̵ÕUÌ$ÕBa+a°@áxøzæú¯¨Û1¦/¬É!ÈbÊÄW§ZHjØÞåK´(·ç¶6}±É©O| âLÄô×ÂÅfÔ½çUÐô¿NVdò)£¾iJ«ÈU²oÎ5N¡xIÔǤIËkàÈês}E¬ÿÒ*ws--d«4­¯EE=e%3ÚGíÊd,8´zã]9)ÍËÌÏNùõØÑ5¼­ºWJxB1RGUòýV´4ùWÜïOÉù«X¶ÛLl[y=£©ú'§Ù$~ ³~ .Pú*¦z·FªE'ÜÕëyòù.,xsD²¾)·âØÞ5PºµUëÓHjú<·Nt

~÷ú¶®=T¿e

@°ÝrF+©gBJkoöya¸²§u0ë¿K5VkdSÃM j3|þf¤µH¢yIü±m¨Ì|¥[ß¾7NxÎÔºTéêÍGC£2Ý'®ªþí­.hy¦ZLlÑ

ØÕ­y6ÂC`q]K8M{½!s$÷:'D¼eSkÞSçy®+4ª,ªQ4¹Q-:øSáî{ã%ë=u-dõ4\´õ"t`"ÿ+þXäW·òæÖMÐRÉ"ëÎãx饭EBÁe¥efOñ/ï

EÖ=9É"&kàóÝUVý¯n_ýÑsô¼`mï/j-OÇQE<uóÈËpOÊÍb?1éêÎ[Så·1¹° Üâ&FK¹

»ÇÒç\77=À§CdT.ÖïõÂyRÜ.yùa5èI2|Æ?¾Aæ ±µû~ê~¸ÇÒåµ9ÇÊ[÷6ÿÑÃl`dµTDü?pÑ<êc?¨(¹ç·dÁK?Ô:57çY¶]«ñ¶yÕû Æ×,Þ

{¢ò¡j±GUËÂd1eVÚö±¶!©ØÕVr­5

·ß¹]®¡FW*9fKò9´½§0¥«§\Ê*'V¦¨X¸R¦àØ~¸Úå¬êz2Óf4ÕéuSÆêGu6[wÇò+8¿+dw£VuÛ¨Yz+rÜÑä<Y£ecìűc)Öýdø2É,=UOî9®W,8ûÞÉzm¬|Â

[E$¬¤SfÐRò9^oÀ¸MðAÕM^ìýêÉS&aÔd²@>Y¸¤²'x·*oïÆ9^e¡³<0hjrüÚ]^U/µauìXqòÅNM˧ò¹LÅùSf3¥R®æ§àð¥Î.ÓrOÎÑ!ÿê..Íù·¢¯¾Ä\qHX;:%DSúÐíXÇåÎ6ÝC÷|ò5ÈcªØmýnâ÷ù

·ÐcÏêSÍ&¾LìÚ,MâR)#_à9öîضÓ[³Xe¿¢\|qÜö0yfYÝÀþ]ÅÊ0þ¯Ó

:I*ÇÞäðOå

ÒY.M[¬5#-évnÛÄ

!Ú7âøýIÇt<0§bã½üÀWÿ17ù¤ø2?ðÓ¬¿¢<ºÿ|¾1

F.ÈXî¨Ösÿ b:\®²¦äVþÐ|Wÿ

xdzKsÙÂSÎ-¾`çù& "ÊBdçµ?ô¯ý144ÁÏY¶E|Q/L4êfܵ÷=£ª$\³QíéEµÀ¥¹Équ¨

Zq¾£ù}å[ìAò<èböMÒÔ&n*xÅU{&Ýaüµùùbß´NeêÖ¢w$çñT_çPSIÕ1<]VÏY^IãÒõ~VÊcAoo8Q7/z ¡%Ãõ0b«.CÊG iéØÿá|]¬jÚ^KõÖAÿÉݵ6±ÅRKJzËyC~IÀ

vÖG ¿üQá¡êæEó?Ò

f#â&?MÊN!/G:̲½HÓr&u$y´ù4~e$l]]är²íÔ@Ó=©(S~æOIvTVSE¨©59Ð>céú_Ϲ3Üâ­Ùå¨öúÛçl¥»Iù±ÈüFjZ!#í30mPkû

ؽCâg\nþûj¦y$rúS-6yq%ö¥É ñUÔJxÊ£¨V;Â絸6Êeþ2uö[{ÁO»§ð¸ÆjMRÁdnfù2YwcHwIå­´ÙRÏýÛ¬¿íÔÐÉFSXèãkͤµ¿âC?dG´>Ú×(Ëä?hßÜÊ2ÌÞQµ@©`üJ1¶å¿j%Rf{=|ܺWO

¯ÓÒ+5´²[ØvF[/ûD´vjäT-6üRåsF=¬quHÛ{

¦¡e8ÈôÛ

ü¹.Ää¹uߥ٥pª)JÆA%6q¹cÜüJ'Öøç¹oj¿Y¦m÷I2*5ókXÐüKÇø¾ß¤Ò©Já¹®Ì

YÆI$ûèÍ^U¥zuÌsɨÏæ͹ìÍbØsa¶ØËê½iQRÁE¥³ª<ÂIái§ï¥7imc´9PBÜÞüÚÜãÓF¬^ÙÞæJ¢3MQ]}沦8!c9Û²¢æÖmÜòÅ8®Íòâó@"yÆóðZ,®?ÅnqbîT61Z²¥*t®ùµkåõ¦A9®¦hfÝü&ÿ

¯~ñÓ_àШL3¾é\Źٸpm{\,åà'Yhó¼ïMUÖ¾

2º÷¨ùYø!ÁBè[»:/|

y§ÉÈ5g=Ty®AÐ-%dÐ%P>õ

ÿ³lx

qß1¬ênäz×RÆ¿&£¥¤_Îxc@6 MÇnÖõÆxÛyoÝ-uz½Pf)

3S0Ф·ß@=OE¿¥r±SÎñbC£þBØ«ì3î°ócÀt.¥R&J´­¼¨;¾\~Îè3´0Ö´2òt`Ûä{ÚþR§VqFùÄñµZCÔ:Ú̯-Ø~úµ"ò²Te± =ÍôÚvM9¥!Ês'Júº

4Jxgm¶RH·

òÆ?©>4Q4©Èé¿Ñlº1BG Ýd@K#÷Ý~xÁºvÅ*±_¡~tÏ@ôz+µÔæÒÉWWX ²mU$kÚüã)âÆh@³ÍÿÓÉOëmç)#ÃÃF¥Ãº¤:TqÊÙ-vc£ºq4®¹ÊÒå PåÇdIk©pŽ}¬=_ ô«¯NtëTQSLºm¦o)O¦ûH½½Ç¾:5$úT5ÖøEºd!ÐpÇçµe&k@ôY­9¨§|·@YmñüJA¨71Jw3ã³3^òXT¿n=9fØÕ`ÕÚa¥)jGÁåÕb¿MÆçsW©>¥­²M<³_̺gÚ¯Må5úC2ËÆa¯W¿u<`6ã~8à{ã¹GfµÈ¿6ÇOÃMºsmcs¨qIä©YJÑ=ÃGÔzÇÐ|Ä_¦©3ùªR=)SjeoóævØßp?Ë7äxõ0xy98øðÕtªpêÌ&«®êN½¥­©Y DZ$v!]ßÍolrOÔ5£¢1åYZµdÿÅ Áº0#vçsckß·%ï4д«¼áþ

ôOH¼ShOäïð|®³|°BÂ6hÝØlª¬Àì=-ÐyîMÓÞÐÓQÑfÒeVªÕzè+aª+¦*Âî­nT)°¹ø»bp÷Vµu¦§ZÓús¬7sÞeTÙU£3]}þWgtôòÀÆpÚ¤¾[&ÁË?±¨äæ¯Uu§§­¦*V³8ëwñ|ÿ?)Y¢Gn%QÈ'h6æøÐÆQÍîoZ05û;zÏ«¾6©¾¯2i¯r)M|P)ãÓlgõƽ­²îfÞµ­Ñz.¯Hi*íSé×7iYó

%¨J1°=Íþ|b

M!J+ch©é¯Kªüõ6èÞ_¨I©5.[¥ë*³vZÄJØ·½9~|¢KXóÈê¾<<;UõÅoI²¡æ5¥©Èsjz|Ê»IÆ0,+ßö#RI3Gé¶[¢<-uG¦PìòmO¦jze©²¸5

ºÇKRRf ¹ 7ÄV×¹"Ýñèv_ë½5à:¦1ËV=h*ÐKyq1RÊ×Öl?v9gH³MwPt@ô¿#£Ô¹ÞG.«Ïè(ªÈòVýØIË¥È|?ùíáixtû0óÌ8j|£[ÿª5Þ#ûÍfUÍs±*¶Øöùà{g!ñiA¥ü Wø\?2Y^p'K3Ù±Ä2ÖâÆÆJÁÔÄãN,ÓT³&ØyÜEåf_××ó

cø¶ílIMò,`¢ÓÄ5»lQ¬Óù^dìjh)j´°£ï`F-§^¥7ÕÑM[ZUW¿Ì6gÑÝ!¯Ç¦2#Ä@÷¸8Á×xQÑõÂI¨é+hg

ÞY±

¸kñ{c«oâÊ{9å|÷ÐôùΦ¦Ìâ Yɧe©*ÛLlw¿?LtcÒíS¯²8s$Ìr<Ö

°Ìæ¹by#PHíèqвñ(ÔÍHcæZ¯

«Ô ¡J§WÊ[®yáÃV´DCeÌËÁûk#äq¨æ}ÕsO§3xÑx,´Í"õ[ÜcÚØxʬT\ðþg˵/êVÞüaò2Ú¯º¤Ô0åôG

;´Uê#B{,¿­±ÔtÿÌ»0x_¡ôç©ôENSU÷

6mHO¿¥;ãçOÞ´Ôõú«1¡Ò-?JºkU^E9JZÚù@ñ¥í`Ö5A`ÍÆìqt­>êÖé}¥{«¯Ó-u{ú^u²ûE|(Kf>:uWE[ÔÓɧhÕ)ê(b0"

T4mÛÝMùÇ"ì²é®_ÕQhÌß5jYüê92Ŷãü§TvMÜùeöúr8Ç:ôhÕ«>&Óô:U)ÖéOI~&çâ[ÃÖëþ[}ó4Öý;Íò{LÇ-¤f×w£öí·Ó1³t#¤Zg¦ÚtRäzÞ|ã5TVfuõÒW×íüK¢«è¾çj«¢ kÕ¥yM¼KÝ3A©û4rUñýXÖÎ>¨¦y>Æ©Im®JAÈm¨Ö$[ñÉÑ|LèµÈ £4ÚÃ)-åL*Zé$fFG8½î

n0¡©JU©ºÿË·Ü[(û­Sß'

éÞ½SÑèþ¤fU:oG)+ê6DëQ0cç¨r9ýLIã©_é>Óô¯MÁ_x2ì·1غù¡wGeÙ¬75ØØsqØbýN4evǼ²Î«}N§'EPG²SÈ£¨60nã·ËUHU9à3{÷ï5$ÖÌ׳à¹I_N$Ù¶H;{÷ÁÆ9*èÀ~!&f·Ö\Ê\¿£úª­+,¨'ª*´Éû£¬LQÃÇaÓ õ~Ð]

XfúÃXõjqéú·¡d¢b|Ú«*yP>6k\·¶:uÕ~~ìNmp{jl¾½ ª7ªfXæTi­þ$ùØrë¯þWÖý{§)(ÑúNA¿xxê*drÿËrAUÿ

|<óle¡oÖÞvD²§¥}E©ê·E2-Q[B¹\ùîXÏF³ùËK½IغÖïad}A*³BB#ÿùCjSè¡8ãúíMe½_QQÓæv¢¦uI«

°I»XM»_<«®3PiüË5¥Õy¹fOXÙ}]a¬T*Þ"ì@,;Yo¨NQÌP#9²)#¢$¥Q

ÕÑ

ýÁÓ¥þh´/R2}MU¬µª¦ÒôÕTÚs-ͪä{6·wøFÕ¸ñ­®Ý(Jçò¼»Aei©S=)ËFs¶×}Ò?½(í´ImÖäúã¬:5¢:ÁeUú¿Käùîc¸z¸w<¬rÜ·ík­ý1]V£-ÖÄ5^ü%iti.sær2G[æ/A<´íÌÈéɹ}q§SÐÿ§y}fcMjf¢VutóHÀ U¿`=q|o& ¢ýHôÂÎQGÖL³WƬù.F¹[J":Eÿ0}¨äãõSÂoV3ñy~¦óáã¥ÇOúWÓ\ã6¢*´¾HÙUn\ÑÞªfH¢ÿc¨WæÑkíÉÑW?ÝìQª`dJ$o¡æÝ5R§Rìt¨¬G:URjEB¹jÍ7Ý)¤®G]¦°êOL¿*Ó>e-.`Åü¦Y®Ãú¸ÏÑ(÷.mrBù=åõ´*òÓCSïÙä¹àün»bÔHt¹%-lãËòÊyÓ3BÜ*[^Ø$¤öhQÂ2yMng¥3*XmZñI#É"HÀr,H¿lMjíGe$ófÓTC6ètsi>oó8ܱËzIO@ïµMTÑT¹^XÒåÂÁ/ÅAýlë­WL4-VgESf9!TóÖy1ÈENXÄ-{ÁNuÊjª\FGöi¬Igµú·*®È+4õ£©¥Y£©ZéIU¦u$H°½ø'_Úq¥[HÔçÙ±¤]45y=]Ý

/aK]ÿÎÉè¦ÒZÖ]¶$ûÜrqtfàù=xrêHê§ÌÑrê=Ó4³0eE+·ýFía~yãMe£+§ªzzhc«ÿ-$¨,£p½·Xíäçö#º3ê<rÕÒH%hÁxâW4»¾ð¢â簭͸ÃÃ.q_¨¦5Ò¾^Ñyn#ùÍkßâEg¸þ l·µ½p¢âÃtWÎ4FW­rÊã.=4ÁK^×*èx±·kK§²mGBµ2GAB±§µD§jÞ¼z÷8¨C9hQ¬Þ&£Öõ9XîÔÙÅjÂ\eõLDÅKìðIäY¯nl1dhú½Bµjɳ¾iKE¼J©OEÌÜï{Iøn-¾ÉMrºÒÏ'$×ËôÞ0ÇïÕõRJg}Ù}2ªãgWK¥Ím)º£ßjþ.Öåk^E8¥ÎYsõü(îÕcu.ë¨n1­ñ-K5x¤4ÊjKÝcr7

¼YÖý#EýqnH®³ wPì`Ékn?þ Åi¤t¸i7vw³w¯?9KÊø

XóT4$¬S?òÎèË/âÚ×õ»·åuqJcG´4Ávþ2²3D-þöâØJdb67O¼)KE¸IñHÿø¸÷ÄvõyHg@î»{ø?1H&f2,ïéøä{ÿÃÏéy>O6c8§¥hÜ°zPàr±þ#-þ}ïêIEeÁeái¡AH­ËðÈ4;Y{ð[××E¢kÚfV¢dÌþpY@ÛÛd@ý}qßÑKT(O©<Ü=

Ôu¹{;RZp&b9H_ÂÿèboÒî<dùÁfÖÛ

v(§Oú¾Q:¨4ËæòÒÊÂçi°°>øyÆØyÆùùl»#ßðHóÍ5³]@gàúú1Ã;,¡r¤ÜÖÝ\Èv;ÈÀì?î4Q¬mt´w~%?Ð>x2+µÀmÊ@»ûc>:'"®ëvþÉîq$ö%L©n*ÌKTü=v8;H7p½úb§É§±`¹Dü7ÇmøýðJÎÇßøÈoñ>÷á`H6ýÎRà|qIKnõ?\E¢)àc¸6åíf6âÀq·ó痢¬w7­Áì1$vE,+p»X%ݽ0/-

IÿyÇËoÅu³ìøÖÿÔǾ+²¬+ÂïØÆËêäÿ ÀîêÝñùmµXc«OL¶Ì!°PêIòÌåòG$[ò­IdLëCf4!Ï>EL6·;H¿ßLoÁ%EÔû+Tg¹Ì!7íÖʶÞr>/êÀûÜã5ø×Ùà"·WçÕªZ'´õFQº"¦2ãá*¶ú|ÍÅ·frÏJʵMfr¦ªZìÅ£jÆ:Áf8ÖDÚ*!!VÖ¸çãϨs¢«Ud·R÷uÊ¢ÊÂKY#çb<ØLSàÏMããXê­iêòý74ìNú£Hë4«ä<Q¡³m

c8°òH㺴C?Òð²Qi];M

k½EzG$öÌ*$FÎ÷cbÌU¬¶

P[¹8­/F]×êAÑ.·åºï?ÒÚnl1¦Ìj*rjyëbÌv¢c(¥Ö?-Û¸üñî¤ëx´?Nõpí2%+Õ5°-·/kÛêìÖMTºðyXxÔÒãCVAQYYaUE^*^l±ªYå,&)èÃn¸.ÂáKr/"åRR&aæ0ÕOGcæÇM*Å+¦ÁYrAã¾¹Eú=¤üâ´¿º# !TôAkN0=[ÊtîµËtÝe~̲Ú<îéâ(VÃ¥%Rò¸<Üãä¶vº

­ï\ã%Þÿ§]9GnMã.й~±ÌVM¦´RýååZ¹) ËX»cÝo.cO1¾#Ö}éÚe©YO¤òhf­$òÖªeZTCa-¬ï

G¥íUmcQ¡ut§.ë·êhTi¸æHÕõ'©uªd¹NÍ)ÒY"¨þ!EW7ÝÜ<¡RHÝK|GuÚÖzëVË´¾* 3¤PCºLáäGe%#òǹðÖµqq[ȯ.¯w?è`¸£®¨ÞW@3CIHí©8l;üN£üñöoÂ~Tyb.Ä«òÔ@«a·½Í/£þ

ÖK÷sC¬ÈSØcë

*¢¸ Ý(Kbãç'.iïlM6Ô4õRå54ðÖýÞo&VÑ6«XÛs'Ò5G¡zûi

Éò|V8̺íh(Ó5<Ê©

|²ÍJ7Ê÷ß½¬95á9¥Ç^QäÕè<xtÛGT.]QS[C,ÉøVÛÁ½À#Ôãg¡ñiÓ²ºMYCSQ¦eMOU#C-M1RË(Þ

Ê\ÀÆiZUô,Wõ)uÆv鿼ã©fM«r̺Xá*LÁQk$iAÈ;d`°¾7õ>¯ÓÅè,Lê

+Å3T,¿tÝ{+=$}|d[ú5£)áÏá±ÈÂz}·+pAº¸ù[Ó¹Û òF\¨b8©l°[í.tWäz0ºAä]K§ª¤Í²|º²iAd§Pò2CÞÿµýÎ6'N¬¡.¨2*Né̾®JÅÊéi'§;uº¸åçjpH\Y¢éåSEK-^RBC´®%]çsoyC¹ø¯Í»X`ê\!ºó{ÉäÅKÓ¼Ç5ÏZêê¯äSM]qìZÕÏê1Ìü=årT±¢Ë²fâ5yµ¹i?#,Û¿¯?LN2];£DozvKåþ¦f$Ï4}u>UU}ªëYe9Û°Ø"Ú·ø®9·Úòhª(aÕͲ?øT¿ÅkßÉ¿¦+MldWqSTEv4çuÕ$`6\ûâ.^ÐjªÊ`¦Ð9xÜ ûÛÊà¥sçÌ!dI;)Þɼ­»ü<òÿ<MOTÔÓKù(¢Ò_ù{ûúbR|!¤,æI¡ Ñ¡3JUTÿJÇòÁæQÇeSÏ'É

¿

µIä}pEzò¦IâUkÞêª7?3/Ùi¹%CCYë;ê¤z'£R×JÔbC5*·-<[ªd@9ßåße=ñÔ¡MF+Ì6xOÃßPëé,±EYåÈà|ñ¤ëd½^Öysxjj©ò̺²»ÈJ©!s.a`³#̯åµÔÛq(¼=56§MLÓy¯[;ÒÂK±#º»^Á¢\÷²Ût¦Ì-Z¬$r£]D0)*ÜÍKIçJ\®ÆKPô×O뺺ÚF5uð54ò$Ì

ÑT

Ç¥ýñ¬å²ý#C©" ¯Îöê?9BËP²®Vo%)¨»ÝßâÜI"æÀ'Qôìéf·Ê)(jóxtþj½¿~§û^ð¹idÀ̲|S9LJ¶?#¾ÑÓº!Seº1ÔîQfU%muM Y³¸o¿8Ût÷Qµé֩Ϋs<9®0¡:&J´)¤åbgBÌHfÞ×zlßs\μUj¨?ÑÚèòLÛ2Ëóé³*ºº´AUT-¾8MãÍ{Yv¯¾2ñõRd´Zg/«ÉâÏs ËÓ<©Jÿ$RIVþZ:+)i~0ÅÂB¨·|^vB]6ë'O5EmF]fkIX£î«¦[LiÚì)eà]¿WuõÐdUùu}Lÿuj½Òùi6*wqùbÖU©¯~-(ßÛÖþÓûÏ/}®KSá%²È7$Ù¦{G6ß.Ë,ü¾~XØ~Ì®Á 2ª²B·9¥ÏÎÈç³mi

?ó5Óùή6Ãk=ñb¥ö|7.ß?áÇ|Ï_jõDøÃÌe¨¡(Z.¬R{ÓyB1ñÿ3òǽã«eÊRP[Gý

ɳ}WK!I¬LòzbcÔò¤þ'bÅÙm¾ô=DÕUt­÷n?1}õG:¯/ý¢ÚrEY+sHu{ññF

§k`¡ÏsG!Z*gÜ,ܶ·®1cÔЫ<eM½?Å%ØIøOrOÄO»`¤½D.ImÄú}0±E½ÔD¬/g?íé7Éf&üþØàXÙ&p!xÚ}Çõ~øÔîÜOÅßèpáó2D l>x¥aå-¢Ë*ÂXìÕ¸ï\^¡@R½Ðmr,=ûâºôªm$IT^Æ72éQÈïUAGY,ÐA©§IÁU$öpGs|i§ÁgMµë´V¨i£ò÷×Ôn@¦Üsç¢Qù4Âúq[&¬û+z?y­þ=H7Ðfä(à72Ècj±ã§+SÅçz¿(ªy§´ñT*2@- úNØç×Ð\^c¹®§>ìÕ3o±B*sð]cTJ¼¦9lmÊ.`Üöç~{ö1ëj(ø~«Óu&Ð&§¨¦gC à]ÍÏËÚMx½Ñª:¤_(Ô3ÿ²s«ÙpEÍÈE>fg7ûE^Y¸ùjìñë&S»hZÚ8ºÕSÌþ++ÞȸË+«a¨QÙÜçºÃ7P4ü².a¡õ^Z&P#yrÉ ¼HR.Ö6÷¾5 ßñ6 &¡ÈâqPÀTòíþ°¦ÊsQ¯N¾àcY­±­@|×ýxÆ{A70k²-à*Wm¬mð/Õ2ß¿ÜH¾}HÙó'TE

ÕNÉ·ñ°ýû`)égXÂeÓ­q,ÝÁúy9?têÓäô®Ëd4ìGÌî~7òÆÊ:ÑUCªµûÄãã7µ¿{'ó=õâÉ4ñìpz°MûÖQÏæ++3Ñ¥ÈoÅÈüûãU¦»uAþî£_y]KxÉå£KÖ>tÛäõE÷'X¤4r2JZö7yHnQȧRÞ\êòýqõ¿jõïéÔuÞ\ZüÏ'¯Ò%FM

ïU@±åÈ.±¾ÓØÿSõ¶2PëL÷)o.Ï0G@ÈY|Ä;¬nUãÚQOÌN

\J~³g´\Õïû­%26ØȺNXâí7|ÞÉ¥È˱´Ûoö£ÁS¡)ÈâóùXD˷ɨæR{vÉA×¼I¦±Âÿ³y¤KÃÊÝö!+oFdiº³§¥ó7f1©§`²»Ëvg2}AGU[I[M+#

dÊÌü_½íòÄ$¹E¢÷3K:UÌ/*3¸þ`VªW¶

ä®àJ³0rx?¶(osBã É2óñü·n

»~øI]¿©·õ'¸ý0È¡ Ü_jñý>øÛÒÌÈ·[#ü=o\h?Ì$Ûóöý0!7ÈEãàí½ûÛôÀ%8ü.¦äÇpªÝñ\`'âO~8'DÆeÊYIU)Ïôç.ʪn¤ùi~áÅ°"6ª°!>DV*I?¶U7qº÷Ø~#ýðȾÞ.]xuãý¡âÿXÄlw$µÜpª}15À&F»Zà÷àHýp,̧{8Þð{Ý<[^áMgrI6Y,2Ò8Ä$­Æ­¯wP¥v môÆ¡§< Óê}?_"glsjjºÚhâ1±ûÇQ+.ФlÜ·Å{yº+¯

nu©oeýyü

«Z&×L¹,ó

çæ¢

|×*«ÍÖ±a|ÄÉÚìewe°;WvÑ}ª

ù°Æ

£Á¹¡YâÉb2ܲæh-¿â¸âæ깿c£k㾦ãlJʤVN_ZË$F«Q´n¸¤?PqEª¾ñ!¸µý½1ì¡$Òìt7ÐôÔz¼g4PÖÍþ±Sñ#RS5ÄE~-îËÛÙèü2æUtÓ_M#ØT§ï*Y×ykYr0çcn1çªëÞ\¥Aìð].Ia©$UÜIFøVçØÂÇÒ

QêrÑ=-]=2Ô´U2¬-±"w?±/{ûb¸k¶Ï*O

vîMÛÍ$ͫ¦¯¥ñ-¥ij饧x³8Ã[VäÝô8ö÷ÿüíÚ×ÈI¥²ÖEH×sHK(°nHÍFq{Ñ[3æé

ÜööÄ *²yÛ»Óô1L`pv|,ÇØâh";B´`·oÃÒ|"2íí·bŬÍ2ÅîÙ¦kMç.ÇÕÈÖÿ

¬ÜúbÚÑÒq>¹%³-¯Tu4h¢]A

E¢Vû{nëµoïaÖDκYKQææ2ÒD)áyQC*muÿSs©éÔæªÓMQ:²k

ôî­ êC#Âò¤YQ?H

ÌÛb|ç¿éM¿­<ôY[1ËÃYl¾Þ¦øãjÐnîù3¥fÿu/©Ö¤¨,GyâçeÌRJvwR7(Ïý*P.êGú.ºûn5Nd0å+]vµöi#ßØO8á¾ë[ø¡dY?jÊ­÷:ïÁúz㶢ð¾ç7}籺¶d§ðé¯|=+ËC2(B¸$æÄóéïKƲôÅlùôå ©ÌzQ]

X©Jyþ®Ü|ñ\W|Îv<å©t­Nè~_ÒxÛvsõ

°Û!IrøO#Ø4߶;§YzAuKíA]ÅY6Ê4ÜtòRÃ1i2âÈ¡m&Ýíl\åþ¬¡Ç;%Ò)Cöski3d¼ÒZ7·Z«Qø¿ÍßÄv,«ÃçH2¬ë1GêZ´®­³Bsj§Låme@¥¶!ݶä÷çÖRaÒØØ|0ÔçÚMxÑù6gÔd:C/«9b½cyÔo®$n(̨o¶Ü­í?Rx®Öº[ÂN©ÉµfpÎgW_]W\+^ie»ÉrV6{Æ*yÇ%¤ÍË|JëZïo-ÌâM!¤´Ê×f=<mçMì\Ãt² <ú=qÅ[í9ë¦é\:ò5Fiæµ¹M}:SÁO5$íÄ^¡ee ÿ#u¥]Gæk©&é¶y#AõÓ­3îç9×P«5vIÔÈ"©l¦¹f¦

§H1q»u0d#nqîâsBRuS7ÑÒg±E¨ò

y*ëé$Uû¤¡ÚFnͪ¤oë

í²½M­ªÉí#x±ñ¹ôÃd]DÐÚ{VÓÔf±åñ°i&¦èîê6!Qô¾]ø̯Ñ×¥y$¹U¯Ô*ZgèRÌÈj¢ä¨Ä?ÓÉÆxY®åó¬ß©3(+ë$¦Öyîeî·6æØç}KñtÏ®WFW岿R'MSGIæRÓÝÊZV$å¿o

OµýOö\C®3/»h,éÙ¿

äÅ¿Þ¸ã#Îèñ'JS.®põyFKpÁÛßÎ1¾$²*ýI§4U_Ä#É3ÍB2Æ%%`&XÅEg"Äh®Ìæ

{4Ù˧¼ð[ªêºÉ¬õ¨I)SCäD¯05­TÔñEðÓSEgmÆîÎn#Ñt]\ÑZ5¦X'ÉòÙò0Σ}­¼VMVàk*¿ºå}VhI?þqqÌ¡²©É

Ï#|6ñ¦U}ü¥YèåŶàCTím£ñ^Øôßö1ú¯_eZ#6Íê/¥+æÌêÄ.æ

8r@íë7Nz­çZ²ÃX»dÉà£A$nIMD®É®¹Á:yqÉÓd¤2*öö8Áæz~j66

n÷ôÃ_2·ÉI3¨ø¹{sld©5³D¡d7÷6ÁØu5­«üË

»bUÔ¹{úF¹Á¸ÆWeñ á[aàzU¨qDçɧݸÁ³bÉF ÌõxÔ-t.¡ã½dïå~#oôõÄ£Â{æ´9D* ¦¨A{#)=íÇ9ΤѶÌrgQ5dô«"w%T;BªÄ¤ú³b{5>È"÷:Ì5*éø-Ë}1

ÕW®ËÖû¯U \ÿ ¶y!£gbÍ3

ºÏÝ^¢I%d4ÈY¯{çÁ´ ¹ME¿Üõü}ñï(øÅÁ(¸pÜû9Jjã-¿ÄlÃÁÞgµyAS"Zh+~`¶5Iú¯4mlÒÓÑÔ¼qüܾ§yú6ü±Ö²ñ5¥Ëq¯©çoü©X¯2ÎnX9WóTëfYFkæ2ª3!

eÃF$onü}{_ß³ÓÅðÑ}§Óe0MdõÓ¤+ì(ds"1î

Ã|±¢óH¡wGÊ¢ð¹ÛÔìi^"»²±uï"å(¾CÔ¹¨Y+jrùw\¥T-ý~%¸¶6ÌSPç-¯¢¯÷&uso 7ý±à¯´KfÜ£ê{m+ÄÖ7ÉySĽ'$ñàW!ñWÖ×fÙ%^YüÖSÝå°kX«\«smÇ|ufÏrô¼=dÃ4ÖËÕ²6ãOK

?ÔÖVbï*]Ô­F«ìÿSµF-Ԣ̵{"¾øÐ=8z

ZÁXülokÛ\u/tåöµB;{©þD(Ü)C­þÐüÖ§+ðoÔ

H>ñ<hc@8oç#? òóPõäßeL]=RI]]¨, xiCRSÜö[ýO4âi®Ïî=W6m

ண#DsWA£$¦7³ýÍ{cúãÈtz¢«ì)]±æUúòѾNdeósuÞø¶Åõu5þtÅ?è{?ÃΦ

Ñ-M

VYÓ-WÉÊoÿñ1ý9¾éC>¤jVPj(÷Ö9oP´¥qÖS×Ðf4ñÔE$2+Ckf±äFTj¼·Fdg_ÐîUjÚ$cÀ]Ì@Ü}äãèÍTòûçmÈ´v¹ÉµÆ\kò,×-Ψ·ÑT¬ñ)Á*M{q¨¨2)Q¡御.v{Jå#­ÞÜméBÑråO'¿8ä*d7-bO õö¾)fÙÅNC£j¢J7®Ïh¨#xÚÌ)O3iô%=ð'a&2fÕnÖ®².ÄmËã!Væ(êßyk@tVçóN)òKÍYÖÐÓ]+

ü-¦ÿÅ-qQZ¯â±dËùbÁ©¾àð}l}

ûcE;yÍuGrq¸µÓ_Z«$Q|¿ø­ª`xÒeó¬ÃðnF»qu'NÕQÐO4Y_x¤Öƪ0/º2OÄ-ÍÆÐ^'§Áa:FYw¯¯¨\²ie©o,!B?°Å}9}(}]Î}§üRimKNä¦lÌ7Tyrjn\Aw2ÄF» ÜÞãß2X>ûL³%¼ÈÀu>¤ûbÚÔ%Oi

K;ÿÂb*÷ïs8Ò­È]õÂÞ£ße½íì¬fRx·¦.ÒçD@fBG&ý!õ,îeéµiH§lâD^lÃ{bì=H¯

ÐDÇðÜú%4

'Éüûa¤B÷&»ïÉô¿ÿ3O}äiºNÌëä ÿíý­ûâ­WSèÉ;©ÐÄkñnR|¡`ÅËÔÃ+¥¦GìB1'·lc³-ëújY)héÙüø%:Wt!CnÁIÝßÇlSR¨±JX19Ïíªc¾i¥4­~þd´êÂÞåTߦsöxô·7¦/ôNe¤«¨§*/Ø䥱T¬)?åܸîh·ìÐÙ¶_,Ni¨òX¥jLéZ¥ácæ(n9ãu¹Ç=Ôcmu9yr}nÉ$Í9þ#îÅJLokXÞÛ{ãÆN£]/×KS9Y4LËìêU ÓfZV±£³+&6wEè_Æ¢û2º©éáÓyòÓJZlÝ¡6j¬¡.Oõ06ïUÎVùº©J[=O=ðSÕ=7,¦·§ZHüß6CKM÷¥Ü8Le¾=ý1¡fCÇÓÚ`ñ(³l.©Ï"¥f¯Ë2sEYW3OIE_X2¨¬i÷¤]Öµ42'ã?ï7ëÈùbSi5ï1c9îÒiS ye$$þK5ǹ±ïÁúUÐ,¹aS#ÁëenE?á¹?ÜóatöeKÉDìÒFɵëY¥³ªü¶*°üí"¼ùQÊ]níßÚËù᥹ÁxÛÌHvûw`$6úòÄSS

»a

µãc»A±0c3)ËáWiÛºàVè-ìô8(×a²

VûËr¢#üÇÿA*¸ã½äBªûÝA½£&?×+Â7² ·æ)þs~KÆ4ÁzÍȪä }¨C@ö4àîR}ïóÀ,Í<aH×xËoñÌ?-?<hE]æ©b×Q·±á¿ù'oü8¯Xà²Çæ

WKÙ~(ÿýX¿üXÓN[°Zȶ¼|Ð|Á·

·îª¿\-_;¾§Ã029Ú?:*Éù*YY1ÐÁ¡ÌîîgáçËSxÿ¼q$M#¹uV©N»Ô$·ýÔÀÞ7(¥ä±ÝKc,ô¿p}þ&ôÅ#

ñ¤K;©tÁ|!?%ç«Vn8Ém8¢ÞiOå´qÌnÔèìx%ÅÌö_|6CFj*©Ìi´½¼¶½Êª;ýN0Õ Ù²}äWi:5)À¢àpçü 4aB

;-~Ûÿ<|&îMÔoæ{ú{E)Ã@Ûý@vãÔâiÆð;qcíßã-É`ÀuF$§éÞtä"

¢®8ÿ³'¨ÝP!LàÍäßýжù²û0Þ

gó_¡ãüMñÃè%&«káfÆTÝko]¨?"7ßnB±ÊÑ9vÚüùcàÍÛR<¯p¤óa$OÊ

:¢ýqª,á¢wb¯æE¹yrâÒ¹úa%´oqàrÙ5÷H~|ÿêØ$*»6þÒÇuãË7¼ÇçÏþ­r@µDI¤Kcÿj~_ò<l=/UQïQ¸CMQ$ßÎDÖoû¿úõÂØOsó7ÆfY

ªñÎ?

¯×

}gÒäf¹0ʬÏ̧¿ ÄcÉ4­'X3ú fo2)*§t[¢í*oðÿDg¸üð`gË

ª~>¤á·ù[7

ÑP{È}ùbIFfPÁæÞ4¤o°-ǧ~øcÝ£ª7ÙÕ¤óÿRÕµ±pR¢[þKöiTÑ:KC¯³ªCÊ2S0+Íî

8õç®9߶dÓUi&V­âD~õö[iCÕZí±eYþô»7¸Ø°&çÖø¡Wá¬TÊ´ÝCËf#H¾lò,ͼ²~!{Eÿ~ôè$þtk|=[ÏVüêÌ×;£#Êòxajdû×ÿDÃ4õ$ø®y?1ssaÛ|Þ:Nÿ@©åÛëdgüñÖ·×mãN1ܪµúOÒø(×ùZnKTHiTþ|Mªz-Õ

ÊdGÓÙñ

aFÕÇÂ%l-ê}qª

VûÊ]]-}Vê2Å.]«(REdpc+©#Û°è1-f¢Ê´Ä¹A6\º¥'§1¥·*v¾ÐÜÚö¾/ò-gºI÷ûг5È©5ö§ÈeÓVæTßuH¢ù<D±oòÀºÿN÷·Ìß¡ë.©]A.b¹{©(fÇ·zFûÂz$·ø®q\ô«J­·°´ÒK'pðÅÕ®z¯¢hªhDUTuÒUO,nD,q\íÜwß´¿A+j?}¥â¦ÛyHÝè

­ØÞø

"ÙÔ½3T*õEÏÓ«úR¶¶ShºAGÊ7nãáÜ6¼¿'ëÜ-'&OÃS%+VÉT±<Ège£H{Û̵ÎÐ̤ÞÖÆ:zmÕ8É*\cîäÊêÁµ°ý;­Ò¦9N¤hrÔûÜÕxÖ¨XÈAräóamôäkÌj*Èß$jiÛ34G"Dì¢áÈfØ/¸n$aÉ®rÔ¡s(Ef{üñ±/Ýtåòdó¾i

Q_

FI©i訦Ø7#*¸ürV-s°´pno~åÓG©*ʺïàÓÓÒBð6äG»»lþÀzþ+âªÕÖjÓÃXßïH%EmÉj_Ùä¢*ü¾y/!ra8¨Rr9-¹p¿<j}NèÞeÒÉãz÷£¢fH$^eöbÌ qLo±ñÊl®vÒ:û|:Ó%G[ô²¿àO`mb.Gî1ö/¢µ1e=:Ë/$!æç*òm ;qè}Å_n

?ÔßgÛ¼s3W­æ+ ^À%| ÿ2¿¼æs.ì»ÌE ï5º/×kGÓ«-áIº51<§ÕO±ÿ)êQõ«Ëº©týv¥ªªh!¡Ä¾kñ®cô±î;ãißG'KeÅvnÒeíWVVFm³"/PZäæøéÐÔWå¥Ûô2NÙÅõʺmKÖ2

ºªz,ÿ3TáPíä£,¼ömý//ÚàçRø ÕZl¢8V=;E5C-ZÁ$Ñ»#"ÄqÁ×ú­_KQhl®¾sJ[îÓSJûþèO*;1b}O¨­Å¥ ýù<ÝAÔ½wÔ&¤ÈõdO<ò­Aª%Ø}7t,¼Ûpdéë~u

³¼ÒE£4ÓB±Æ­Q¤TIÚ¤~XvßÐ$²úÏÂÔ5ïN¿õJ¨´9qC=

,ü1Æ°`°2F·ÿw^ÖYßJüôùô¤O÷üÏXfAjUJSAnÿ!ű$òÚ^¡ÂLú-CHÙP²$¢D5 Âê68åRÚâ?SdÞi¼dÑÚz»ÃOþ¦ºÌP²ìêL®6P¹ù¢8¾8(Vïn6ÊÜÝÆïÔJÏü#GæPݯ`å!짺ôþ§;tj5zz·3û%´`TKê¬Æº°Å´²Å2òÅ­øy·6Çbë=ïÚá÷*gGeñ(%~òm?0êaËnÙ&ÛVêlã¤#Ä]UYÕæÚ®+ ]©SQ+ ÝM1ØrãVéo]

ÑUyö}.SK§i5¤2vZú&idUÞwö;¢é

ѳþøÞcþù5_

õ¥wìôÌÞ\ôñ÷Yªãй¿O³§LIÒÒ>{ªu

u-q`¶é¶Á{]¹íÉ8)f>¸$ÓMüÎÙásÄƹ¦ëþmÒ¾¢¾Ì3Ê:F®¹\>WJ$'°

×G \nØícz쫤YìòÔE"-¾am²8·¯#ëmí5ôÇl·ìòLg$ÐÄgb¾¢O2WÚó

IíÛ?ÅKº]Qê=.3Ü«+¬òéê¡8e¤1ºFYU;<aÉó@º#ZI¨¿C

ÚÊmw;ë¿N<;d]$éîY¨^ÓTÒPMSåµuùC$&¢}ûe/qÜob?

±èM?ÖܪÆÖeùIåÔ¿{¤Ë³ÊCM]""z pYbW!î¹7A=ñgYø¥éÆñAÒÇ9¨§ÖÊÒ±¥I%¢

æ½Gámê.A8Cé[¬·^é-CÔIô¤Ë*5$3ÑËu¨Y DyÅ@øÐ{Y»ã'ÓÜÃ"ê¥EVÔ9F ¥¥¨jI¥Ëª¡"M6*M~þ~^VS#ò6,FSjÚj:Ê*èF䥨I]MB@`x#¸ÆÁM¡¨r

RáIì,y¶"¶Y7º³-ÈÑVÃ>à£p±¹8â]ñEu×/ÕuT´QSe¢¿&ÊÍ*¸óé©Ø Ëw-ºäXqÛ9Y`Þè²Ìê`Ó»môóÆÏièèµÇ8XØYy,Vg1ÑXöñëéS8tÍêîRB-æEð¿æ}<C$Þ

wý/¬È3jÄÌ¢£\Af~å¾Õ`®zî?;x·s¹Æ¼Êólÿ!²°UgBTzyÓlY|ÃvëÚÛ¤µýøïß6É·4U¡+]§|Ø}ÿ<a5$Qft¤I]à`dlßâçó÷ùbQ}JªO¢.^Ë|dfoTí&Mȼ¨LÊåoÚæãöÆnÆ-¡Z¬71å ©Kü¾$úø. :»(£í1)8×¢Ñ˼\é:isê0ßÍ¡ÿ]­þXØh÷Ðô^>ÒëµK¥¿S1Y[¦ú§êòÙs=Ñ×DñIFÅéVàµù>µÕðâ'3ɵ.[®ÆQSBóÁ-,´uª¤Ðme7<÷4ZwôjÎXxÊÉÒ¾AÃ)Æ^£´ç@ò­éxóýª)³Ü¬¡dAÇá%Nå#± Þüc[áÇXdeÕÏ)6uîóîã¹õW= Ló'­¦ Jè%§cèÔ©ý/] ¦­ê¼Ò="/x¨r­W5EL¬ì\KARì-Å£

ÏÈÊ-hÒýÝYK¶ä«>=ïâ÷ª§£^5NwDÌ^è²èË[uDÊR ?îÌ~HqÃþȺ(iºUgÿô¦eEIÅL ³rdÐzbpéÓêTõio÷¾Ðl

zýãG£Ý9I,Ì"Y

ªÓÏ#ùì-êÑ@w 6õÆÑöõK è÷}IM4½/¤¤§

ey|L­,ÁG

«µcQêÌ}6[Âsû-ý2{ì¹Ó?è

<¯2ÓIY5z­¬Z5o"+üÈBI÷cMÕ<2ûK"üCå>:=jÜáAOjjvýn¥Øaõfî?¬xµñF¡AÜW¥$·¨IÓP#Ïf=iâg7êz³03/¯/HÒ/!$iøA²Ú×õÆçÑÿ9WYüMfZ)Ëâ%¤mp&bk&ÜÂÛ-`c7½\+Ý%ªÕcOeuÓK«z²`T¹ÜüýñÕË%^S§#±¨Õ«#öX©¤aûMqhÚ¨²ñLkP¿©8³,ßwPT´nÜà~F¶¸ÖË´n°ç·s4ÁclE»­½~xH\n£é: sÜ¡wÃeõ,?ÅæÄËýÈǧFNé­zõB[ÕâjWk'ðü°Âp¤k~$")Zÿ0}1ßÒjÓjw3ÕËØïØéðjúúÚIGRÅ:ôþ¨Y>ðÛOjJ½]Ñh3Æf ËþîD(×󬒩 üqk^ôÓª³ëü¿?ÌzuÃåõ«TfóL°H V{±¿7<_nméÖÅý2BÄÜÞ:yâë7¡§Í[æ:³,(lþj­7[÷ÚhÛ%¬Å¼ÔNb²±

ÌÌ #ZÍ´n¸<cl´×Ôú^ݲjûJ|Z6Öh¯Ðùvg;g´5GXÿÔ¦©[î§s`ò@ââÀ¾³ëÖéÖuCAê»(¯ÌØ

Zj©BÉ5ûp/`O«Xa­§Vºq¾2]´6Ö4´P4³ÔE

<`VØ~×cÀ1ú_­Ô«ö .EÑ×ÓP¥*ArÝ'-r

øÆhQMúãên©ÓÍ:nÌH±Ú?,W©ÌÙá¨þLVóIäÂÕêÓPÓe/UYdTÁLÇùÅÝG²POÌbÀFE¼kz[

r<YÃzp=þõÛâîG6ôÄÖ9 Ù]¦!&×kÂ=±Z|®;©Y¤¥«iSÊVK²£V>À?Ìî©iãÐiú|èƸ§ÌißvÐ{]ÔÄÜð-´cê?]NÑèç0éÞ©Sgt¢iA±æ=ܽïôR[Bâ-îÎè¼Ó$îõ´Y|ì^5M;ÂÉñÂÆ3u/¿vnqo³º:¦ð¬ôÇO¿ÒJò³EÞV¼4®Ò廤2ñLré`Svy¼õðÊâ[V

Uv!'êR¦­T ÞIã?ËèÿÌĪ®$tc;bWHó[òB~Þ¸ÜÅmå= ¹*xãÐÿXÇþQ­$fÞ²r-n6î·nÿø±l

$nYìÍîAOW6ü­Ô·SV5ËÎ×#±Y9ý¶,2VÞ

RndÚÉüÁÕÇçßDÎ$

/{pq9¿ÈqCÉ$£a

+¡y!yâź%¼Á ¾àÅ;»Já÷Æj¯²"Ìh¼èãeSd"|@ý[°õÆk@äÿ}Î)KF¯,s:ÞÛQ1ùòqͽ«ÓBOätíaÕ4z+¢Zj(ãrxOÌ@¸ä1¹;ã&ßãâ%d÷1Ù jÝZ@9*OøÁ}ÄÂä|_+v¯"l×:»:ÁÓíÆU¢p"÷_÷í#×hü¹éX=-15kíøI

Doùíý±õV©JÞ¤ ñDyaÕ~>«§Tl^97:îI/µ¤'þàb­oMa2!¥Fºükxò7?<}"«Q|hóR è«þ÷ýÎ6CT¦þ-Ýv)O§kb¹¥c_åHÁAÓz7~ÿúõÅI)æEþrÏ

ÈDÿ*

~¿úïÔî)Ëx²¹A­[TâaTEä9)aNÿ¼õß|É3)\ª¢8îlaÚ 'Üþ§m)LñÊ!jXw ûºßlÛõý½°4ÓAh¤¿®#oö%?õÿ^$4d-ÚËÌ_ù)ÍßvimüûcúâHк,eØ

®æãWûaª*^Z v2«òöÐ`

vE@Æ%kZÑ·,ÿ®mR

+¡µ­å¢r§êØ®6Ö0YV¡[l

måþx³EUen¦hÄnÄS2nÙãqMnY2ô=KÏèG¹

T¦;Áµ?7uÀÅên»gpÄ7µ5AReÁ]¼JÜQ¯Óíc>_K(|Êe-kÚ÷àbÔfÊÐÚzj¡å0Ù1nGéÝ»ìBTÌ7TrI×ùµScÉã#K¬òÌÆDXs*$Ñ S

½ïnmÝ9"=/ê\Â:½¯F©]s

$£yÜYPñr;)î\V,Kf47

OSÛrZHÁÿËöc

De izquierda a derecha: Mariano Ventosa, Director ETSI ICAI; Andrés Serrano, DG Structuralia; José Domínguez, Rector Universidad Alfonso X; Jose Alberto Plaza, Director CECO; Isabel Fernández, Directora Escuela Politécnica UEM; y Marcos Luengo, Presidente IDESIE

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

De izquierda a derecha: Mariano Ventosa, Director ETSI ICAI; Andrés Serrano, DG Structuralia; José Domínguez, Rector Universidad Alfonso X; Jose Alberto Plaza, Director CECO; Isabel Fernández, Directora Escuela Politécnica UEM; y Marcos Luengo, Presidente IDESIE

De izquiera a derecha: Jesús Rodríguez Cortezo, Presidente CGCOII; Juan Santamera, Presidente CICCP; Miguel Ángel Carrillo, Decano CICCP Madrid; Eugenio Fontán, Presidente COIT; y Rafael Fernández Aller, Presidente FEANI.

The war memorial in the churchyard was originally erected in 1900 in memory of Major L. H. D. Fortesque of Castle Hill, who was killed in action in the Boer War. It was rededicated after the First World War and now carries the names of the fallen of the Boer and First and Second World Wars.

"L.H.D.F. Lieutenant Viscount Ebrington Royal Scots Greys

killed at El AlameinsJuly 17 1942.

Grenville Fortescue Captain 11th Rifle Brigade killed at

Laventie Sept. IV MCMXV. Third son of Hugh Third Earl Fortescue He was born on XIX November MDCCCLVII at Castle Hill. To the memory of one who never wearied in helping others

"Erected by his friends and neighbours of all conditions in

the county of Devon.

Lionel H. D. Fortescue Major Second in Command XVII Lancers. He fell in the action of Diamond Hill in South Africa on June XI MCM and was buried hard by the field of battle.

Frederick J. Harris Trooper VII Batt. Imp. Yeo. died aged XXVIII

at Pretoria Oct. MCM.

Charles Hulland Private II Batt. Devon Regt. died at Standerton

June VIII MCMI aged XVII."

William Blight L’Cpl. 9th Devons killed in France Apr. 11 MCMXVII

Frederick Blight Pte. 8th Devons killed in France Sept. XXV MCMXV

Walter Blight Pte. 1’6th Devons died at Basra July XVIII MCMXVII.

Frederick Bendle Pte 6 Devons killed in Mesopotamia Mar. VIII MCMXVI

Arthur Pugsley Pte. 1st Devons killed at La Bassee Dec. XX MCMXVI

Arthur Gregory Pte. 1’6 Devons killed in Mesopotamia Sept. XXVIII MCMXV.

Henry Palmer L’Cpl. 1st R.D.C. killed at Ypres Oct. X MCMXIV

George Steed Pte. 1st Gren. Gds. died Oct. XXI MCMXVIII

Thomas Stone Sgt. R.N.D.H. died at Alexandria Oct. XXVIII MCMXV.

Not here they lie not here but far away

in other earth by other grass o’vergrown

yet by their home this cross shall stand and say

they dwell among their own.

And further dedicated to the honour of all brave men of this parish of Filleigh who like him shall lay down their lives in the service of their country.

Private Josiah F. Fry Cheshire Regt. killed at Sheffield Dec. 13 1940

Signaler Gordon William McRae R.N. killed at sea Feb. 8 1943

Gunner Henry Tucker R.A. killed in Italy May 23 1944

Gunner Gerald Greenslade R.C.S. killed in Italy July 21 1944.."

www.devonheritage.org/Places/Filleigh/Filleigh1914-1918Wa...

Lewis Clarke CCL www.geograph.org.uk/photo/4121530

Maria Jesús Prieto Laffargue, past president de la WFEO, durante el acto de apertura del I Congreso Internacional de Formación y Movilidad en el sector de la ingeniería organizado por Madrid Centro Mundial de Ingeniería.

Pompei, santuario della Beata Vergine del Rosario

La storia del Santuario è legata a quella del Beato Bartolo Longo, suo fondatore e della contessa Marianna de Fusco (moglie del conte Albenzio de Fusco), con la quale condivise una vita al servizio dei più bisognosi. Il Santuario è stato eretto con le offerte spontanee dei fedeli di ogni parte del mondo. La sua costruzione ebbe inizio l’8 maggio 1876, con la raccolta dell’offerta di “un soldo al mese”.

La facciata

Ha aspetto basilicale ed è caratterizzata da due ordini sovrapposti. L’ordine inferiore, in stile ionico, presenta centralmente un corpo avanzato in corrispondenza della navata centrale. In quest’ordine sono presenti tre arcate (con la centrale maggiore) che immettono al portico e quindi ciascuna ad una navata. Nella parte bassa di quest’ordine è presente un robusto basamento dal quale si elevano, in corrispondenza di ciascuna arcata, pilastri (per le arcate laterali) e quattro colonne monolitiche di 6.80 metri di granito rosa (per l’arcata centrale). Tali pilastri e colonne hanno basi attiche e capitelli ionici.

L’ordine superiore segue la disposizione di quello inferiore, nella distribuzione dei pilastri e delle colonne, ma in stile corinzio. Nella parte centrale dell’ordine superiore, ovvero al di sopra dell’arcata maggiore, è situata la Loggia Papale, caratterizzata da una balaustra di marmo bianco. L’ordine superiore presenta una cornice, abbellita con mensole, e nel mezzo un frontone, nel cui timpano è collocato lo stemma in marmo bianco di Papa Leone XIII, dal quale il Santuario è stato dichiarato Basilica il 4 maggio 1901.

Alla sommità dell’ordine superiore è presente un attico con balaustra. Ai lati di quest’ultima sono posti un grosso orologio (a sinistra) e una meridiana di pari dimensioni (a destra). Al centro invece, su di una robusta base, è collocata la statua della Vergine del Rosario. Tale statua, opera dello scultore Gaetano Chiaramonte è alta ben 3.25 metri ed è stata tratta da un sol pezzo di marmo di Carrara dal peso di 180 quintali. Sulla base su cui poggia la statua, è scolpito il motto “PAX” (Pace) cui l’intera facciata è dedicata e più in basso la data MCMI (1901).

Nel portico della facciata sono collocate quattro nicchie ove poste le statue in marmo di Padre Ludovico da Casoria, del Beato Luigi Guanella, di S. Leonardo Murialdo e di Francesca Saverio Cabrini, nomi legati alla storia del Santuario

Il campanile

La posa della prima pietra del campanile avvenne il 12 maggio 1912. Dopo tredici anni, il 24 maggio 1925 avvenne l’inaugurazione con una solenne cerimonia in presenza di Bartolo Longo (che allora aveva 84 anni). Il campanile sorge su una palizzata in cemento armato di una superficie di circa 400 m2. Architettonicamente la struttura è costituita da tre parti: l’esterna, decorata di granito grigio; l’interna di mattoni pressati; una terza centrale composta da un’armatura a castello di travi metalliche che forma una torre di collegamento, dal peso di 100000 Kg, che sostiene una scala in ferro che conduce fino alla sommità. Il campanile è visibile anche a chilometri di distanza in quanto è alto ben 80 metri e presenta al vertice una croce di bronzo alta 7 metri (illuminata di notte), opera dell’arch. Aristide Leonori. È in stile corinzio ed è caratterizzato da cinque ordini sovrapposti, all’ultimo dei quali è presente una terrazza con balaustra, raggiungibile mediante ascensore interno, visitabile tutti i giorni e dalla quale è possibile godere di una notevole panoramica che va dalle isole del golfo fino all’Appennino, agli Scavi, al Vesuvio e alla Valle del Sarno. Al primo ordine è presente un monumentale portone splendidamente decorato. Una nicchia al quarto ordine racchiude una imponente statua di 5.5 metri e dal peso di 180 quintali in marmo di Carrara, rappresentante Gesù. Ai quattro angoli del terzo ordine sono invece posti quattro grandi angeli in bronzo che danno fiato alle trombe. Un sistema elettrico mette in funzione un concerto di otto campane, di differenti dimensioni e quindi di suono. La campana maggiore ha 2 metri di diametro e pesa 50 quintali. Tali campane, riccamente decorate, furono formate dalla fonderia Marinelli nel cortile della allora proprietà Falanga in Via Sacra, a poche decine di metri dal Santuario, usando 100 quintali di cannoni di guerra, cui si aggiunsero 50 quintali di rame e una quantità proporzionale di stagno per ottenere i 180 quintali di bronzo necessari.

Mariano Ventosa, director ETS de Ingeniería-ICAI, Adrés Serrano, director general de Structuralia, José Domínguez, rector de la Universidad Alfonso X, José Alberto Plaza, de CECO, Isabel Fernández, directora de la Escuela Politécnica de la Universidad Europea de Madrid, y Marcos Luengo, presidente de IDESIE de la UPM, durante la segunda mesa redonda titulada Centros de formación privados, en el I Congreso Internacional de Formación y Movilidad en el sector de la ingeniería, organizado por MCMI.

"The Teak House," view of the Living Room from a sketch in water-colours by A. Wickham Jarvis, Architect [I have superimposed the title from the tracing paper leaf that protects the colour plate.]

[A plate from "Modern British Domestic Architecture and Decoration" edited by Charles Holme, offices of "The Studio", London, Paris, New York, MCMI. Page 107 (The Studio was a leading architectural review of the day and remains a major source of information to this day.)]

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

María Jesús Prieto Laffargue, Past President de la World Federation of Engineering Organizations (WFEO), Manuel Niño, Secretario General de Infraestructuras, Pedro Canalejo, Presidente de Madrid Centro Mundial de la Ingeniería (MCMI), Marina del Corral, Secretaria General de Inmigración y Emigración, y Manuel Moreu, Presidente del Instituto de la Ingeniería de España durante el acto de apertura del Congreso Internacional de Formación y Movilidad en el Sector de la Ingeniería.

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

Maria Jesús Prieto Laffargue, past president de la WFEO, durante el acto de apertura del I Congreso Internacional de Formación y Movilidad en el sector de la ingeniería organizado por Madrid Centro Mundial de Ingeniería.

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

FDA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

FDA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

FDA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by April Finnen

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

María Jesús Prieto Laffargue, Past President de la World Federation of Engineering Organizations (WFEO), Manuel Niño, Secretario General de Infraestructuras, Pedro Canalejo, Presidente de Madrid Centro Mundial de la Ingeniería (MCMI), Marina del Corral, Secretaria General de Inmigración y Emigración, y Manuel Moreu, Presidente del Instituto de la Ingeniería de España durante el acto de apertura del Congreso Internacional de Formación y Movilidad en el Sector de la Ingeniería.

April 28 - May 1, 2015; In partnership with the University of Texas Medical Branch (UTMB), FDA’s Medical Countermeasures Initiative (MCMi) sponsored a week-long training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Hosted at the National Institutes of Health in Bethesda, Maryland, this annual course is designed to educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies product approval via the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible.

DA welcomed course faculty and participants from government, industry and academia. International participants in 2015 included representatives from public health agencies in Liberia, Canada and the UK. The course included expert lectures and hands-on laboratory activities conducted in Biosafety Level (BSL) 2 and BSL-4 training laboratories to emphasize the differences between biosafety levels, and the complexity of conducting laboratory activities in a BSL-4 environment.

To learn more about the course, visit: www.utmb.edu/orncs/FDA_Partnership/

To learn more about the FDA MCMi, visit: www.fda.gov/medicalcountermeasures

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/

FDA photo by Diane Garrett

De izquierda a derecha: SG EFCA; Presidente FEPAC; Presidente Fundación MCMI; Director Escuela Ingeniería y Teconología TEC Monterrey; Directora Escuela Politécnica Universidad Europea Madrid; SG Infraestructuras Ministerio Fomento; SG Inmigración y Emigración Ministerio Empleo; Past President WFEO; DG SERCOBE; y Presidente Instituto Ingeniería España